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Abstract
Sexual reproduction of Toxoplasma gondii occurs exclusively within enterocytes of the definitive felid host. The resulting
immature oocysts are excreted into the environment during defecation, where in the days following, they undergo a
complex developmental process. Within each oocyst, this culminates in the generation of two sporocysts, each containing 4
sporozoites. A single felid host is capable of shedding millions of oocysts, which can survive for years in the environment,
are resistant to most methods of microbial inactivation during water-treatment and are capable of producing infection in
warm-blooded hosts at doses as low as 1–10 ingested oocysts. Despite its extremely interesting developmental biology and
crucial role in initiating an infection, almost nothing is known about the oocyst stage beyond morphological descriptions.
Here, we present a complete transcriptomic analysis of the oocyst from beginning to end of its development. In addition,
and to identify genes whose expression is unique to this developmental form, we compared the transcriptomes of
developing oocysts with those of in vitro-derived tachyzoites and in vivo-derived bradyzoites. Our results reveal many genes
whose expression is specifically up- or down-regulated in different developmental stages, including many genes that are
likely critical to oocyst development, wall formation, resistance to environmental destruction and sporozoite infectivity. Of
special note is the up-regulation of genes that appear ‘‘off’’ in tachyzoites and bradyzoites but that encode homologues of
proteins known to serve key functions in those asexual stages, including a novel pairing of sporozoite-specific paralogues of
AMA1 and RON2, two proteins that have recently been shown to form a crucial bridge during tachyzoite invasion of host
cells. This work provides the first in-depth insight into the development and functioning of one of the most important but
least studied stages in the Toxoplasma life cycle.
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Introduction
Toxoplasma gondii is an important zoonotic parasite that can
infect a wide range of warm-blooded animals, including humans,
with sometimes serious sequelae [1–3]. Like other Apicomplexa,
Toxoplasma has a complex life cycle, in this case involving asexual
replication in almost any warm-blooded animal and sexual
reproduction only in felines. The latter culminates in the shedding
of oocysts into the environment where they mature and persist as
highly infectious forms. Infection of humans can result either from
the eating of undercooked meat containing the asexual bradyzoite
cyst stage or ingestion of mature oocysts as environmental
contaminants of water or vegetables [4]. The relative importance
of each route of exposure is not known as the methods to
distinguish between tissue cyst and oocyst infection are still being
developed [5,6]. Nevertheless, epidemiologic studies support an
important role for oocysts in transmission: the prevalence of
toxoplasmosis is not reduced in vegetarians [7] and outbreaks tied
to the ingestion of contaminated water have been reported
globally, [8–12].
Oocysts are the product of a complex sexual reproduction that
begins with ingestion by a feline of an infected prey [13,14]. The
encysted bradyzoites are released during digestion and these
initiate a complex sexual development within the enterocytes of
the cat’s small intestine. After fertilization of a macrogamete by a
microgamete, a zygote is formed and this is shed into the intestinal
lumen as an immature oocyst about 3–7 days after ingestion of the
infected prey. This is a highly efficient process with a single cat
able to shed as many as one billion oocysts during a primary
infection [13,15,16]. Upon defecation, the immature oocysts are
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released into the environment where they undergo a complex
developmental process that starts with a single, relatively
amorphous zygote and ends, after exposure to appropriate
environmental conditions, with 8 discrete sporozoites subcom-
partmentalized within two sporocysts. Mature oocysts have been
reported to survive and remain infective for years in fresh water
[17] and for at least twenty-four months in salt water [18]. Their
extreme resistance to treatments such as bleach, acid and
ultraviolet makes them an important public health challenge.
This also poses an interesting biological question: how can such a
complex developmental process as sporulation occur within such
an environmentally self-contained cyst?
Once ingested into an intermediate host, the wall of the mature
oocyst must be ruptured and the sporozoites within must initiate a
new infection by invading into intestinal epithelial tissue.
Relatively little is known about both these processes although
the sporozoite appears to have all of the organelles that recent
work has shown are key to invasion by the asexual tachyzoites, i.e.,
micronemes, dense granules and rhoptries [19,20]. Interestingly,
invasion by sporozoites appears to involve a two-step process that
includes formation of a spacious primary vacuole from which the
sporozoite then escapes by formation of a tighter vacuole that
superficially appears more similar to the one formed by an
invading tachyzoite [21]. The molecular details of this complex
invasion process are largely unknown. Similarly, almost nothing is
known about how the sporozoite interacts with the infected host
cell, especially compared to the recent detail that has emerged
about the many virulence factors that tachyzoites introduce into
the host cell during invasion [22]. Several dense granule proteins
have been shown to be common to tachyzoites and sporozoites
[21] but all such work has been dependent on having antibody
reagents for the tachyzoite proteins as a starting point.
With recent advances in genome sequencing, a whole genome
approach has provided a new way to discover and interrogate
genes/proteins/pathways involved in a variety of processes, such
as pathogenesis of disease, growth, adaptation, stress, and host-
pathogen interactions. Among the most powerful methods that
have been developed are microarrays to examine expression
profiles for the entire transcriptome of a given organism. Such
studies have markedly advanced our understanding of the biology
of multiple organisms and disease states by providing information
on gene regulation across different conditions and life stages. The
Toxoplasma gondii genome sequence predicts ,8,000 genes and an
Affymetrix microarray with probesets representing all predicted
genes (based on ToxoDB release 4) was recently developed and
made commercially available [23]. Prior to the availability of this
gene chip, most studies looking at gene expression in T.gondii,
including developmental regulation during asexual development,
utilized smaller scale custom microarrays [24–27], reverse
transcription polymerase chain reaction (RT-PCR) [28,29],
expressed sequence tag (EST) analysis [30] or serial analysis of
gene expression (SAGE) [31].
The goal of the current study was to understand the complex
development of oocysts and gain insights into the functioning of
the sporozoites within. The approach we chose was to use the
Toxoplasma gene chip to characterize the transcriptome of oocysts
throughout development and compare this to the expression
profiles of the better-characterized tachyzoite and bradyzoite
stages. Several groups of abundantly expressed genes were
identified as up-regulated during oocyst development, including
many that provide clues to their environmental resistance and to
other functions, such as sporozoite invasion, that are specific to this
key developmental stage.
Results
Given our goal of interrogating gene expression across both the
sexual and asexual stages of Toxoplasma development, it was
important to have a strain capable of efficiently completing the
entire life cycle. For all this work, we used the M4 strain isolated
from an infected sheep in Scotland and kindly provided by Lee
Innes of the Moredun Institute. Based on its European origin and
the fact that, at each of 4 polymorphic loci, it was found to have a
DNA sequence identical to that of the canonical Type II ME49
strain (see materials and methods), it is assumed that M4 is a type
II strain. The oocysts used in this study were isolated from the
feces of experimentally infected kittens within the first 24 hours of
being shed. This material was also incubated for 4 and 10 days
after shedding in conditions that allow oocyst maturation; these
three time points represent immature (day 0), maturing (day 4) and
mature (day 10) stages of oocyst development, respectively.
Immature oocysts have yet to develop individual sporocysts or
sporozoites; maturing organisms generally have recognizable
sporocysts but few if any discernable sporozoites within those
sporocysts; mature stages mostly have the full complement of 8
sporozoites subcompartmentalized as 4 organisms in each of two
fully developed sporocysts (Figure 1). Using light microscopy to
visualize oocysts on a hemocytometer, approximate percent
sporulations were obtained. Day 0 oocysts were 100% unsporu-
lated with only a primary sporoblast visually detected (d0,
Figure 1). In the duplicate d4 samples, 52% and 78% of the
counted oocysts had two distinct secondary sporoblasts/sporocysts,
and of these, less than half had discernable sporozoites within (d4,
Figure 1). In the duplicate day 10 oocyst samples, 95% and 99% of
the oocysts had two sporocysts with a vast majority containing
discernable sporozoites (day 10, Figure 1).
For comparison purposes, we used tachyzoites of the same M4
strain cultured in vitro by growth on human foreskin fibroblasts
(HFFs) and bradyzoite-containing tissue cysts harvested from the
brains of mice 3 weeks after oral infection with oocysts.
Preparation of RNA from oocysts requires first rupturing the
oocyst wall which is, probably as a result of evolutionary selection,
very resistant to most treatments. For this, we used a French press,
similar to a previously described method [32]. The result was a
relatively low yield, (about 1.4 mg in the d4 and d10 preparations
and ,10 mg in the d0 preparations, each from ,56106 oocysts),
but this was more than sufficient for the microarray analysis. For
the bradyzoites, tissue cysts were prepared from infected mouse
brain 21 days after infection. This time point was chosen because
the numbers of cysts in the brain are near their peak and animals
do not survive much beyond this time using the combination of
infectious load, parasite strain and mouse strain employed here. In
fact, to enable adequate tissue cyst numbers to be obtained and to
prevent premature death of the animals, it was necessary to
provide a low dose of sulfadiazine in the drinking water.
Tachyzoites presented their own challenge with this strain as it
grows considerably slower in culture than the usual laboratory
strains, even other type II strains (data not shown). Nevertheless,
sufficient material was easily generated for ample RNA prepara-
tion by growth of tachyzoites in human foreskin fibroblasts.
Duplicate RNA samples from all five stages, tachyzoites,
bradyzoites and the three developmental stages of oocysts, were
prepared and used as the starting material for transcriptomic
analysis using the Affymetrix Toxoplasma gene chip [23]. To
evaluate differences in transcript abundance across the sample
groups, the probesets with corresponding version 5 gene IDs
(ToxoDB.org v6.4) that were found to meet statistical criteria for
differing levels of expression for each comparison group (p,0.05)
Toxoplasma gondii Oocyst Transcriptome
PLoS ONE | www.plosone.org 2 February 2012 | Volume 7 | Issue 2 | e29998
were assembled. The tables report the mean of the generalized
logarithm (glog) expression values for each duplicate sample and
fold-changes in expression levels between different pairs of
developmental stages. To estimate the background levels of
expression, the median glog value was calculated for each sample
group for 14 control probesets, encoding the luciferase, DsRed,
Green Fluorescent Protein (GFP), ZsGreen, ZsYellow and
chloramphenicol acetyl transferase (CAT) genes, for which no
transcript should exist in our samples. The median range of
expression for this control set was 3.1–3.2 across sample types and
this, therefore, represents the approximate background value. A
table showing the corresponding percentiles of expression for glog
values is provided as a supplemental table (Table S1). Details of
data normalization, glog transformation and the method used to
calculate fold-changes are provided in the materials and methods
and prior publications [33–35]. The complete list of all probe-sets
with significant comparisons is provided as a supplemental table
(Table S2). An in depth analysis and validation of the bradyzoite
dataset as compared to the tachyzoites (only) is the subject of a
separate report [36].
Validation of stage-specific gene expression
A limited set of developmentally regulated genes has previously
been identified for tachyzoites and bradyzoites and a more limited
number in mature oocysts. To determine if these sporozoite-,
tachyzoite- and bradyzoite-specific genes are regulated in these
datasets in the way expected, a sample of the best-studied such
genes was analyzed (Table 1). These include the canonical
bradyzoite genes enolase 1 (ENO1), lactate dehydrogenase 2
(LDH2), bradyzoite antigen 1 (BAG1) and two surface antigen-1-
related sequences (SRSs), SRS9 and SAG2X [35,37–39]. Canonical
tachyzoite genes include ENO2, LDH1 and the surface antigen
genes SAG1 and SAG2A [40–44]. RT-PCR and SAGE have
identified differentially expressed genes in oocysts as compared to
tachyzoites and bradyzoites, including those encoding the
sporozoite-specific surface antigen, SporoSAG, and two putative
oocyst wall proteins (TgOWPs), which are homologues to known
Cryptosporidium OWPs (COWPs) [31,45,46]. Table 1 presents the
mean normalized (glog) expression values across the samples and
the fold-changes in the comparisons. Expression profiles in this
dataset were consistent with previous descriptions of stage-specific
transcripts confirming that the biological material, RNA prepara-
tion methods and microarray analyses used here are providing a
faithful representation of the developmental forms under study,
albeit with certain caveats due to technical limitations discussed
further, below.
Patterns of gene expression across oocyst maturation
time points
As the oocyst develops from the unsporulated, freshly excreted
form to a fully sporulated and infectious stage, significant changes
are taking place. The sporocyst walls are formed and the oocyst
accrues its full infectious potential through sporozoite formation. It
was therefore expected that the developing oocyst would be
transcriptionally active and that by looking at the gene-expression
patterns at three stages in its development, unique patterns would
be revealed and that these would provide clues to developmen-
tally-regulated genes in the oocyst that are relevant to its
maturation and environmental stability. For this analysis,
comparisons were made between the transcriptomes of d4 versus
d0 oocysts, d10 versus d0 oocysts and d10 versus d4 oocysts. In the
three comparisons made, the greatest number of genes with
significantly differing transcript levels occurred between d4 and d0
(2,362 significant genes) followed by d10 versus d0 (2,233
significant genes), with comparatively fewer significant genes
found to differ in the d10 versus d4 comparison group (830 genes).
Comparisons between d10 oocysts and the tachyzoite and
bradyzoite stages identified 1,850 and 1,771 genes as significantly
different in their expression, respectively (Table 2).
Lists of the top 30 genes that were found to be significantly
changed in their expression levels (either higher or lower) in each
of the oocyst time-point comparisons were generated and are
provided as a supplemental table (Table S3). As predicted, a
number of genes related to sporozoite development were found to
increase in transcript abundance in the d4 oocysts compared to d0.
Within the top 30 list of significant changes showing the largest
fold-increases in d4 compared to d0 oocysts were genes encoding:
13 hypothetical proteins, 3 of which were tyrosine-rich (defined as
.5% tyrosine); 3 late embryogenesis abundant domain-containing
proteins (LEAs); 3 micronemal proteins (MIC10, MIC 11 and
Figure 1. Toxoplasma gondii oocyst preparations used for transcriptomic analysis. Oocysts were harvested from cat feces as described in
the materials and methods and isolated directly (d0; unsporulated) or after 4 (d4; mid-sporulation) or 10 (d10; sporulated) days of exposure to
sporulation conditions. Day 0 oocysts are unsporulated with a primary sporoblast. Day 4 samples include unsporulated (arrowhead), partially-
sporulated (star) and fully mature oocysts (arrow). Day 10 samples contain mature, sporulated oocysts.
doi:10.1371/journal.pone.0029998.g001
Toxoplasma gondii Oocyst Transcriptome
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MIC13); two SRS-family proteins (the previously described
SporoSAG and SRS3); 2 dense granule proteins (GRA1 and
GRA7); 2 PAN-domain-containing proteins; 2 antioxidant pro-
teins (a putative glutathione/thioredoxin peroxidase and a
superoxide dismutase, SOD3); a putative eukaryotic aspartyl
protease; a putative serine protease inhibitor (TgPI-1); and a small
heat shock protein 20 (Table S3). The timing of increased
expression of secreted and surface-antigen-related proteins is
coincident with the formation of sporozoites within the oocyst.
Interestingly, an even greater number of genes had significantly
lower transcript levels in d4 versus d0 oocysts, of which nearly half
are hypothetical proteins. These may reflect genes involved in the
later stages of macrogamete development and oocyst formation
occurring in the feline intestine; i.e., genes that function in earlier
stages of the parasite’s sexual cycle (e.g., gamete formation and
fertilization), stages that are difficult to obtain and that were not
available for analysis in the current work.
A list that combines the top 30 changes from all of the pair-wise
comparisons between the three oocyst time points, which includes
135 genes, is displayed as heat-maps (Figs. 2 and 3). Tachyzoite
and bradyzoite expression levels are included for comparison.
Within this list are a number of gene transcripts that were most
abundant in the d0 oocyst compared to later oocyst, bradyzoite
and tachyzoite stages. In addition to several hypothetical proteins,
gene transcripts specifically elevated in d0 oocysts included two
meiotic recombination proteins, (DMC1-like and SPO11), two
Table 1. Validation of gene expression comparing known developmentally-regulated Toxoplasma gondii genes.
Mean glog expression (SEM)
Regulation Gene ID1 Product2 d103 Tz4 Bz5
Fold-change* [fold-change
lower]
Higher in Tachyzoites Tz vs. d10 Tz vs. Bz
33460 SRS29B (SAG1) 8.4 (0.02) 9.3 (0.07) 4.6 (0.02) - 46.0
68850 ENO2 5.3 (0.08) 7.4 (0.09) 4.2 (0.10) 4.9 8.0
32350 LDH1 6.9 (0.02) 6.0 (0.08) 5.1 (0.28) [2.0] 1.8
71050 SAG2A (SRS34A) 6.4 (0.01) 8.4 (0.09) 6.0 (0.06) 6.0 8.4
Higher in Bradyzoites Bz vs. d10 Bz vs. Tz
59020 BAG1 3.6 (0.54) 6.2 (0.18) 10.0 (0.01) 125.0 34.5
68860 ENO1 2.7 (0.06) 5.2 (0.16) 9.4 (0.03) 76.9 35.7
91040 LDH2 3.1 (0.14) 4.9 (0.25) 9.2 (0.03) 58.8 34.5
120190 SRS9 (SRS16B) 3.3 (0.06) 4.1 (0.15) 5.6 (0.10) 2.6 2.1
7140 SAG2X (SRS49B) 2.4 (0.20) 4.7 (0.03) 6.6 (0.09) 6.3 3.4
Higher in Day 10
Oocysts
d10 vs. Tz d10 vs. Bz
58550 SRS28 (SporoSAG) 9.5 (0.02) 4.5 (0.17) 4.1 (0.05) 55.6 63.2
9610 oocyst wall protein COWP,
putative (TgOWP2)
8.8 (0.02) 3.3 (0.19) 3.9 (0.13) 38.5 34.0
48730 oocyst wall protein,
putative (TgOWP5)
7.5 (0.04) 3.9 (0.12) 4.6 (0.07) 10.0 7.8
Mean normalized, glog-transformed expression values and calculated fold-change in expression levels for each pair-wise comparison. The standard error of the mean
(SEM) is given in parentheses.
1TGME49_Gene identifier according to ToxoDB.org (v6.4).
2Identity of protein assigned by ToxoDB.org (v6.4).
3Day 10 sporulated oocysts.
4in vitro-derived tachyzoites (2 dpi).
5in vivo-derived bradyzoites (21 dpi).
*Fold change calculated from glog mean expression values back transformed to the original scale (see materials and methods) and shown only where values are
significantly different, p,0.05.
doi:10.1371/journal.pone.0029998.t001
Table 2. Summary of numbers of genes with significantly differing levels of gene expression in pair-wise comparisons of oocyst
maturation time points and between mature day 10 oocysts and tachyzoites and bradyzoites.
Comparison Total number of significant genes Up regulated in comparison Down regulated in comparison
day 4 vs. day 0 oocysts 2362 938 1424
day 10 vs. day 0 oocysts 2233 889 1314
day 10 vs. day 4 oocysts 830 431 399
day 10 oocysts vs. tachyzoites 1850 1022 828
day 10 oocysts vs. bradyzoites 1771 929 842
doi:10.1371/journal.pone.0029998.t002
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scavenger receptor proteins (TgSR1 and SR2), a Tat-binding
protein-1 interacting protein (TBPIP)-domain-containing protein, an
aldehyde dehydrogenase, a glutathione S-transferase, an enoyl Co-A
hydratase, a putative oligosaccharyl transferase STT3, a major
facilitator family protein, an LCCL-domain-containing protein, a
BTB/POZ-domain-containing protein (TGME49_063010), a U2
snRNP auxiliary factor small subunit, a C protein immunoglobulin-
A-binding beta antigen, a putative tropomyosin 1 alpha chain, and a
putative FK506-binding protein 1. In all pair-wise comparisons, a
large number of the significantly changing genes were ‘‘hypothet-
ical’’ proteins, which have not been characterized or been ascribed a
putative function. These appear likely to have functions specific to
one or other developmental form. The identification here of the
stage in which they are most highly expressed will help provide clues
to their function.
Oocyst-specific transcripts
To identify genes specifically relevant to the mature oocyst, two
comparisons were performed: d10 oocysts versus tachyzoites (tz)
and d10 oocysts versus bradyzoites (bz). In addition to the
transcriptomic analysis presented here, preparations of d10 oocysts
were also processed for proteomic analysis, including separated
wall and sporocyst fractions, as described in the accompanying
manuscript [47]. While the focus of the proteomic work was
specifically on the wall composition, and no proteomic data were
generated for the earlier time points in development (i.e., d0 and
d4 oocysts) or for tachyzoites or bradyzoites, the protein data do
provide important validation for the expression of some of the
novel, oocyst-specific genes discussed here. The gene lists to be
discussed below, therefore, include an indication of whether there
is proteomic evidence for each gene’s expression in d10 oocysts
and, using data present in ToxoDB (v6.4), in tachyzoites (several
tachyzoite proteomic datasets can be found within ToxoDB and,
for these purposes, we considered them in aggregate). Because the
proteomic datasets that are being compared were generated in
different labs using different methodologies, no attempt was made
to draw quantitative conclusions about relative expression; hence,
we simply scored a given protein as either detected or not. The
criteria used to score a protein as detected in the oocyst proteome
required a minimum identification of two unique peptides. No
minimum criterion was set for tachyzoites, which were scored in
the tables presented here as ‘‘detected’’ if any peptide identifica-
tion for the given protein had been reported on ToxoDB. It is
important to note that the absence of proteomic data for a given
protein has only limited predictive value as there can be many
technical reasons for failure to detect a protein. These data, then,
are mostly useful for a positive result, i.e., to confirm a gene’s
expression. This is especially the case for the oocyst proteomic data
where only one lab’s efforts are available. For the tachyzoites, five
independent datasets exist on ToxoDB and so a failure to detect a
given protein in any of those five sets is a still imperfect but more
likely indicator that there is little if any expression in that stage.
The comparisons of the transcriptomic data for d10 oocysts,
tachyzoites and bradyzoites were assembled into a single list
comprising the top 25 genes with the greatest fold-increase in d10
oocysts compared to both tachyzoites and bradyzoites (Table 3).
Many of the genes in this comparison had even higher expression
in d0 and/or d4 oocysts, but only the d10 transcriptome was
compared to the transcriptomes of tachyzoites and bradyzoites. As
a result, some of the genes listed here also appear on the list of
genes with the highest expression in d0 oocysts. Included in the list
here are genes encoding: 2 late-embryogenesis-domain-containing
proteins (LEAs); 2 antioxidant proteins (glutaredoxin and
superoxide dismutase - SOD3); one outer wall protein (TgOWP2);
one haloacid dehalogenase-like protein; one oxidoreductase family
protein (alanine dehydrogenase); one SRS-family protein (Spor-
oSAG); and 16 hypothetical proteins, 5 of which are tyrosine-rich
(.5% tyrosine). Several of these genes have been shown elsewhere
to be specifically elevated in oocysts/sporozoites, including:
SRS28/SporoSAG [45]; the putative OWPs [46]; SOD3 and
glutaredoxin (TGME49_027100) [48]; and one LEA, designated
TgERP for embryogenesis-related protein and corresponding to
TGME49_076850 [5]. Seven putative oocyst wall proteins have
been identified in the ToxoDB, based on homology to Cryptospo-
ridium OWPs (COWPs). Of these, one is in the top 25 list of
significantly up-regulated genes in oocysts (TgOWP2; Table 3).
Four LEAs are designated in the TGME49 genome, all of which
were significantly up-regulated in oocysts compared to tachyzoites
and bradyzoites and 2 of which were in the top 25 list. As can be
seen in this Table, 18/25 (72%) of the genes that are strongly up-
regulated in d10 oocysts compared to the two asexual stages also
have proteomic data to indicate expression and only 12% have
proteomic evidence for expression in tachyzoites. While these data
are not quantitative, especially as regards the failure to detect a
protein in the oocyst dataset, as discussed above they do provide
strong corroborative support for the microarray data.
Patterns of expression for genes encoding surface
antigens and secreted proteins
Toxoplasma tachyzoites invade a host cell by attachment and
active penetration followed by growth within a parasitophorous
vacuole (PV). Many studies have shown the remarkable extent to
which tachyzoites modify their intracellular environment, presum-
ably to promote their own replication. Attachment, invasion and
intracellular survival are apparently facilitated by the tachyzoite’s
surface antigens and the protein contents of their secretory
organelles; micronemes (containing MICs), rhoptries (containing
ROPs and RONs) and dense granules (containing GRAs) [49].
Much less is known about sporozoite invasion but in vitro studies
have shown that the sporozoite temporarily occupies a primary PV
before it moves into a second PV where the parasite replicates
[21]. Virtually nothing is known about how the sporozoite
interacts with the host cell at the molecular level. Given the
possibility that the sporozoite utilizes a unique, two-step method to
create the parasitophorous vacuole and the fact that there is
essentially only one host cell type encountered by sporozoites (i.e.,
intestinal epithelial cells), it might be expected that the oocyst/
sporozoite would have an unusual repertoire of surface antigens
and secreted proteins. These then became the focus of our
analysis.
Surface antigens. Developmental regulation of the SRS
family of genes has been well described in tachyzoites and
bradyzoites [24,44]. The SRS proteins are designated as such
based on their structural similarity to the major, immunodominant
surface antigen SAG1 (also known as SRS29B or P30) which is
abundantly found on the surface of tachyzoites and which was the
Figure 2. Heatmap of the average normalized expression values (glog) of ribosomal and hypothetical genes in the top 30 genes
with significantly changing expression levels, higher and lower, across all pair-wise comparisons of oocyst time points. Expression
values for tachyzoite and bradyzoite stages were included to highlight genes that appear to be oocyst-specific and those that resemble tachyzoites
and/or bradyzoites in their transcript levels. The range of expression is represented by a color grade ranging from low (blue) to high (yellow).
doi:10.1371/journal.pone.0029998.g002
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first Toxoplasma surface antigen to have its cognate gene sequenced
and complete protein structure determined [50,51]. Although
varied in their specific immunogenicity and function, SRS proteins
are involved in host cell invasion at the level of attachment and
recognition by the host cell (thereby influencing host immune
response). The hallmark surface antigen in sporozoites is SRS28,
or SporoSAG [45], but the surface antigen repertoire of the
sporozoite is not limited to SporoSAG. Surface antigen genes
previously shown to be expressed in both sporozoites and
tachyzoites by SAGE and EST data include SAG1, SAG3 and
SRS3 [31]. Those results were confirmed in the microarray data
reported here; Table 4 shows a complete list of SRS genes with
Figure 3. Heatmap of the average normalized expression values (glog) of the top 30 genes with significantly changing expression
levels, higher and lower, across all pair-wise comparisons of oocyst time points (ribosomal and hypothetical genes not included,
shown in figure 2). Expression values for tachyzoite and bradyzoite stages were included to highlight genes that appear to be oocyst-specific and
those that resemble tachyzoites and/or bradyzoites in their transcript levels. The range of expression is represented by a color grade ranging from
low (blue) to high (yellow).
doi:10.1371/journal.pone.0029998.g003
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significant differences in expression levels between oocysts and one
or other of the asexual developmental forms. Interestingly, the
repertoire of SRS gene expression in oocysts more closely
paralleled tachyzoites than bradyzoites; that is, many SRS genes
that were up-regulated in bradyzoites relative to tachyzoites were
generally ‘‘off’’ in oocysts (e.g., SAG2C/D/X/Y, SAG4, SAG4.2 and
SRS22A), whereas several SRS genes that are up in tachyzoites
relative to bradyzoites were also expressed at substantial levels in
oocysts (e.g., SAG1 and SRS3). Surprisingly, SAG3, a SRS protein
that is common to tachyzoites and bradyzoites [52] showed
transcript levels that were ,11- and 27-fold higher in d10 oocysts
compared to tachyzoites and bradyzoites, respectively. This level
Table 3. Top 25 genes with significantly higher expression in day 10 oocysts compared to tachyzoites and bradyzoites, with day 0
and 4 oocysts included for comparison.
Mean glog expression (SEM) Fold-change* Proteomic evidence
Gene ID1 Product2 d03 d43 d103 Tz4 Bz5 d10 vs. Tz d10 vs. Bz Oo6 Tz7
002100 hypothetical protein 11.4 (0.54) 10.1 (0.22) 9.9 (0.05) 3.5 (0.20) 3.7 (0.35) 111.1 103.3 Y N
037080 hypothetical protein
(6.2% Tyr)
11.2 (0.52) 9.6 (0.35) 9.6 (0.05) 3.6 (0.22) 3.7 (0.03) 90.9 84.6 Y N
120530 hypothetical protein
(5.6% Tyr)
6.3 (0.13) 9.9 (0.15) 9.4 (0.07) 3.3 (0.20) 3.6 (0.20) 76.9 69.7 Y N
002110 hypothetical protein 11.0 (0.46) 9.0 (0.63) 9.4 (0.05) 3.1 (0.18) 3.8 (0.09) 76.9 63.8 N N
076850 LEA (TgERP) 4.9 (0.07) 10.4 (0.13) 9.4 (0.02) 3.5 (0.31) 4.4 (0.05) 71.4 55.4 Y N
076880 LEA 4.3 (0.13) 10.2 (0.14) 9.3 (0.02) 3.5 (0.03) 3.8 (0.04) 66.7 60.0 Y N
081590 hypothetical protein
(15.5% Tyr)
5.9 (0.01) 10.6 (0.07) 9.9 (0.08) 4.9 (0.04) 4.6 (0.28) 66.7 77.6 Y N
120540 hypothetical protein 10.5 (0.65) 9.2 (0.28) 9.2 (0.04) 3.7 (0.01) 3.8 (0.11) 52.6 51.7 N N
098560 hypothetical protein 6.3 (0.07) 9.5 (0.19) 9.1 (0.02) 3.09 (0.22) 3.9 (0.23) 58.8 48.0 N N
059900 hypothetical protein,
conserved
4.1 (0.02) 10.3 (0.08) 9.0 (0.11) 3.1 (0.11) 3.6 (0.02) 55.6 47.5 Y Y
058550 SRS28 (SporoSAG) 5.7 (0.14) 10.2 (0.07) 9.5 (0.02) 4.5 (0.17) 4.1 (0.05) 55.6 63.2 Y N
094600 hypothetical protein 6.7 (0.14) 9.5 (0.22) 9.2 (0.07) 3.7 (0.12) 4.3 (0.15) 52.6 43.9 Y N
027100 glutaredoxin, putative 6.9 (0.67) 9.9 (0.15) 9.2 (0.05) 3.2 (0.02) 4.4 (0.17) 62.5 45.7 Y N
119890 hypothetical protein
(5.5% Tyr)
4.7 (0.29) 10.3 (0.04) 9.3 (0.04) 5.5 (0.13) 4.2 (0.04) 26.3 51.2 Y N
087250 hypothetical protein
(13.5% Tyr)
11.0 (0.44) 8.6 (0.73) 9.1 (0.02) 4.3 (0.01) 3.6 (0.09) 41.7 50.7 Y N
066860 BTB/POZ domain-
containing protein
10.9 (0.54) 8.3 (0.93) 9.1 (0.00) 5.6 (0.09) 3.8 (0.19) 21.7 48.2 N N
004520 hypothetical protein 6.0 (0.02) 9.5 (0.31) 9.0 (0.17) 3.4 (0.10) 4.0 (0.14) 50.0 42.3 Y Y
116190 superoxide dismutase,
putative (SOD3)
4.9 (0.05) 9.9 (0.08) 9.0 (0.07) 3.8 (0.18) 4.4 (0.22) 45.5 37.8 Y N
009610 oocyst wall protein COWP,
putative (TgOWP2)
10.7 (0.44) 8.4 (0.74) 8.8 (0.02) 3.3 (0.19) 3.9 (0.13) 38.5 34.0 Y N
070950 hypothetical protein 6.5 (0.03) 8.9 (0.45) 8.7 (0.04) 3.8 (0.28) 4.5 (0.18) 31.3 25.3 Y N
029320 haloacid dehalogenase-
like hydrolase domain-
containing
10.2 (0.31) 7.9 (0.46) 8.5 (0.02) 3.4 (0.14) 3.8 (0.05) 29.4 26.2 N N
072240 hypothetical protein 5.2 (0.03) 8.7 (0.34) 8.5 (0.01) 3.4 (0.15) 4.3 (0.06) 28.6 22.1 Y N
002090 hypothetical protein 10.4 (0.20) 8.0 (0.440 8.5 (0.02) 3.4 (0.00) 3.7 (0.11) 28.6 26.3 N N
115260 alanine dehydrogenase,
putative
8.5 (0.02) 8.4 (0.17) 8.4 (0.03) 3.6 (0.22) 4.4 (0.39) 25.6 19.8 Y N
005090 hypothetical protein 9.0 (0.34) 8.4 (0.59) 8.4 (0.02) 3.7 (0.14) 4.1 (0.39) 24.4 21.5 N Y
Mean normalized, glog-transformed expression values and calculated fold-change in expression levels for each pair-wise comparison. The standard error of the mean
(SEM) is given in parentheses.
1TGME49_Gene identifier according to ToxoDB.org (v6.4).
2Identity of protein assigned by ToxoDB.org (v6.4).
3Oocysts sporulated for 0, 4 or 10 days.
4in vitro-derived tachyzoites (2 dpi).
5in vivo-derived bradyzoites (21 dpi).
6Detection in day 10 (mature) oocyst proteome. Yes (Y) indicates that a minimum of 2 unique peptides mapping to given protein were identified by mass spectrometry.
7Previous mass spectrometry evidence of expression in tachyzoites according to ToxoDB.org (v6.4).
*Fold-change calculated from glog mean expression values back transformed to the original scale (see materials and methods) and shown only where values are
significantly different, p,0.05.
doi:10.1371/journal.pone.0029998.t003
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of up-regulation is approaching that of the better-known SporoSAG,
which showed 56- and 63-fold higher transcript levels in d10
oocysts relative to tachyzoites and bradyzoites, respectively. Both
these genes showed much higher levels of expression in the d4 and
d10 oocysts compared to d0, presumably reflecting induction
as sporozoites begin to form. The proteomic data strongly
corroborated the d10 oocyst microarray results: i.e., with one
exception, there was a perfect correlation between having a glog
expression value above 6 and being expressed (and there was no
protein detected for genes with glog values below 6). The one
exception was SRS42, which had a glog expression value of 4.6 but
a positive detection in the d10 oocyst proteome. The correlation
was less strong for the tachyzoite data but, as predicted, SAG3 but
not SporoSAG, has been detected in tachyzoite proteomes.
Secreted proteins (MICs, ROPs, RONs and GRAs). Mic-
roneme proteins (MICs) are associated with parasite motility and host
cell invasion [53]. All but two microneme proteins that were
generated in the list of significant comparisons between oocysts and
the two asexual stages (.3-fold difference in at least one of the
comparisons) had significantly increased expression in the d10 and d4
oocysts compared to d0, including MIC1, MIC2, M2AP, MIC3,
MIC4, MIC5, MIC10, MIC11, MIC12, MIC13, MIC16, AMA1, an
AMA1 paralogue and a putative microneme protein (Table 5). Two
genes encoding microneme proteins, MIC13 and a putative
microneme protein (TGME49_115550), had significantly higher
transcript levels in day 10 oocysts compared to both bradyzoites and
tachyzoites and may represent micronemal proteins most relevant to
the oocyst/sporozoite stage. The proteomic data generally
corroborated the microarray results with most MICs detected in
both the oocysts and tachyzoites. The only micronemal proteins not
detected in the tachyzoite proteomic data on ToxoDB were all in
cases where the glog expression value was below 4 in tachyzoites.
Rhoptries are secretory organelles that release their contents
during host cell invasion. The rhoptry neck proteins (RONs) play a
key role in host cell invasion. Several of the RONs collaborate with
micronemal AMA1 to form the moving junction (MJ), a ring-like
interface between the parasite and host plasma membranes that
migrates down the length of the parasite during invasion [54–56].
Table 4. Expression of functionally interesting genes of Toxoplasma gondii oocysts at different stages of maturation with a
comparison to bradyzoite and tachyzoite expression levels - SRS family proteins.
Mean glog expression (SEM) Fold-change* [fold-change lower] Proteomic evidence
Gene
ID1 Product2 d03 d43 d103 Tz4 Bz5
d4 vs.
d0
d10 vs.
d4
d10 vs.
d0
d10 vs.
Tz
d10 vs.
Bz Oo6 Tz7
058550 SRS28 (SporoSAG) 5.7 (0.14) 10.2 (0.07) 9.5 (0.02) 4.5 (0.17) 4.1 (0.05) 59.3 - 28.3 55.6 63.2 Y N
108020 SAG3 (SRS57) 4.7 (0.21) 8.2 (0.28) 9.0 (0.02) 6.3 (0.03) 5.0 (0.06) 15.3 - 31.2 11.1 26.8 Y Y
101150 SRS8 (SRS19B) 3.5 (0.20) 3.5 (0.25) 3.1 (0.07) 4.3 (0.13) 3.2 (0.09) 1.3 - 1.3 5.6 2.2 N N
058810 SRS27B 4.3 (0.20) 7.9 (0.20) 6.4 (0.04) 3.5 (0.07) 4.5 (0.10) 13.0 [3.7] 3.6 4.4 3.2 Y N
108840 SRS3 (SRS51) 6.2 (0.08) 10.3 (0.12) 9.4 (0.06) 8.0 (0.01) 5.0 (0.00) 43.7 [2.4] 17.9 3.8 38.9 Y Y
119350 SRS domain
containing protein
5.4 (0.11) 8.2 (0.31) 7.0 (0.04) 5.3 (0.14) 5.4 (0.11) 9.8 [3.0] 3.3 3.5 3.2 Y Y
067130 SRS38A 4.0 (0.06) 7.0 (0.31) 5.5 (0.08) 4.4 (0.16) 6.2 (0.11) 6.5 [3.2] 2.1 1.8 - N Y
038440 SRS22A 4.5 (0.21) 4.5 (0.05) 4.7 (0.06) 3.9 (0.21) 9.3 (0.01) - - - 1.3 [43.5] N N
033460 SAG1 (SRS29B) 5.4 (0.22) 8.0 (0.63) 8.4 (0.02) 9.3 (0.07) 4.6 (0.05) 8.3 - 13.1 - 19.0 Y Y
115320 SRS52A 4.2 (0.08) 5.8 (0.50) 6.4 (0.04) 5.6 (0.14) 4.4 (0.16) 2.3 - 3.6 - 3.4 Y Y
034370 SRS42 4.4 (0.17) 6.9 (0.04) 4.6 (0.07) 4.4 (0.12) 4.5 (0.02) 5.0 [4.9] - - - Y N
024170 SRS domain-
containing protein
3.9 (0.15) 3.5 (0.25) 3.0 (0.42) 4.0 (0.05) 7.0 (0.03) - - - - [7.8] N N
007130 SAG2Y (SRS49A) 4.4 (0.13) 3.3 (0.00) 3.2 (0.10) 4.9 (0.15) 7.2 (0.11) [1.4] - [1.4] [1.7] [9.1] N Y
007140 SAG2X (SRS49B) 3.7 (0.23) 3.0 (0.20) 2.5 (0.20) 4.7 (0.03) 6.6 (0.09) - - [1.3] [1.9] [6.3] N Y
007160 SAG2C (SRS49D) 5.8 (0.36) 4.5 (0.36) 3.9 (0.35) 5.5 (0.15) 7.2 (0.01) [2.2] - [2.5] [2.0] [7.9] N N
080580 SAG4.2 6.1 (0.15) 4.1 (0.25) 3.9 (0.20) 5.5 (0.08) 8.9 (0.00) [2.8] - [3.0] [2.0] [38.5] N N
007150 SAG2D (SRS49C) 5.2 (0.37) 3.8 (0.03) 3.6 (0.19) 5.4 (0.32) 7.6 (0.02) [1.8] - [1.9] [2.1] [12.1] N N
085870 SRS20A 4.1 (0.02) 4.8 (0.09) 4.8 (0.02) 7.2 (0.08) 6.1 (0.06) 1.3 - 1.3 [5.6] [2.2] N Y
071050 SAG2A (SRS34A) 5.3 (0.40) 7.6 (0.38) 6.4 (0.01) 8.4 (0.09) 6.0 (0.06) 6.1 - - [6.0] - Y Y
033480 SRS2 (SRS29C) 4.1 (0.04) 4.0 (0.31) 3.9 (0.11) 7.6 (0.24) 4.2 (0.12) - - - [11.1] - N Y
Mean normalized, glog-transformed expression values and calculated fold-change in expression levels for each pair-wise comparison. The standard error of the mean
(SEM) is given in parentheses.
1TGME49_Gene identifier according to ToxoDB.org (v6.4).
2Identity of protein assigned by ToxoDB.org (v6.4).
3Oocysts sporulated for 0, 4 or 10 days.
4in vitro-derived tachyzoites (2 dpi).
5in vivo-derived bradyzoites (21 dpi).
6Detection in day 10 (mature) oocyst proteome. Yes (Y) indicates that a minimum of 2 unique peptides mapping to given protein were identified by mass spectrometry.
7Previous mass spectrometry evidence of expression in tachyzoites according to ToxoDB.org (v6.4).
*Fold change calculated from glog mean expression values back transformed to the original scale (see materials and methods) and shown only where values are
significantly different, p,0.05.
doi:10.1371/journal.pone.0029998.t004
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The rhoptry bulb proteins (ROPs) appear to serve a downstream
role, modifying the host-cell environment for the parasite’s own
purposes [57–59]. The microarray data yielded many significant
changes in expression of rhoptry genes (Table 6). As seen with the
SRS and micronemal genes, markedly increased transcript levels
were observed for several ROP- and RON-encoding genes in d4
and d10 oocysts relative to d0.
In tachyzoites, RON2 is known to directly interact with AMA1
during moving junction (MJ) formation and host cell invasion [54–
56]. Both AMA1 and RON2 are expressed in d4 and d10 oocysts
with transcript levels comparable to tachyzoites (Table 5 and
Table S4) suggesting the usual tachyzoite-like MJ machinery
operates in this stage. While the RON2 glog levels were relatively
modest, in percentile terms they show expression ranging from
44th percentile to 62nd percentile in tachyzoites and d4 oocysts,
respectively (as opposed to 9th percentile for the d0 oocysts where
their expression appears to be essentially off; Table S4). In
addition, however, there was a specific up-regulation in d10 (and
d4) oocysts of paralogous genes for both RON2 (so-called ‘‘RON2-
like2’’ or RON2L2 in table 6 which we will hereafter refer to as
‘‘SporoRON2’’) and AMA1 (the ‘‘AMA1-paralogue’’ of Table 5 that
we will hereafter refer to as ‘‘SporoAMA1’’). Combined with the fact
that the expression data for these two paralogues in both
tachyzoites and bradyzoites was close to background levels (a glog
expression value #3.7 for both genes in both asexual stages), these
results strongly suggest that there exists a novel, sporozoite-specific
alternative to the tachyzoite form of the MJ. Consistent with this,
there was proteomic detection of both these novel paralogues in
the d10 oocysts but no such evidence for expression in tachyzoites
(Tables 5 and 6). A second RON2-paralogue, RON2L1, was
detected in the oocyst, but not in the tachyzoite, proteome.
Expression values for RON2L1 were ,5 across all oocyst,
tachyzoite and bradyzoite samples, with no statistically significant
difference in any comparison; therefore, it does not appear in
Table 6. Of the other three components of the MJ, RON4, RON5
and RON8, only RON4 has a known paralogue, RON4L1. This
gene’s expression was significantly higher in bradyzoites than in
d10 oocysts (,2.7-fold), but did not statistically differ in other pair-
wise comparisons. RON4L1 expression was relatively low in day 10
oocysts (4.4), versus tachyzoites (5.3) and bradyzoites (6.2). In
agreement with these transcript expression data, there is proteomic
evidence of RON4L1 in tachyzoites, but not in oocysts. Hence, it
Table 5. Functionally interesting genes of Toxoplasma gondii oocysts at different stages of maturation with a comparison to
bradyzoite and tachyzoite expression levels – micronemes.
Mean glog expression (SEM) Fold-change* [fold-change lower]
Proteomic
evidence
Gene
ID1 Product2 d03 d43 d103 Tz4 Bz5
d4 vs.
d0
d10 vs.
d4
d10 vs.
d0
d10 vs.
Tz
d10 vs.
Bz Oo6 Tz7
060190 MIC13 5.1 (0.25) 10.0 (0.09) 8.6 (0.04) 4.4 (0.01) 6.7 (0.05) 67.2 [3.8] 17.7 24.4 6.1 Y Y
067680 MIC12 5.7 (0.48) 9.0 (0.04) 7.0 (0.03) 4.9 (0.15) 7.2 (0.08) 18.7 [6.6] 2.8 4.5 - Y Y
115550 microneme
protein, putative
4.7 (0.04) 8.0 (0.29) 6.3 (0.05) 3.5 (0.17) 3.8 (0.13) 12.1 [4.4] 2.7 4.0 3.7 Y N
004530 MIC11 5.2 (0.10) 9.8 (0.06) 9.4 (0.04) 8.4 (0.06) 7.9 (0.07) 57.8 [1.6] 35.7 2.7 4.0 Y Y
050710 MIC10 5.5 (0.13) 10.0 (0.08) 9.7 (0.13) 8.7 (0.02) 8.5 (0.05) 55.8 - 42.2 2.5 3.1 Y Y
115540 microneme
protein, putative
6.6 (0.44) 7.3 (0.33) 5.7 (0.08) 3.5 (0.12) 3.9 (0.05) - [3.7] - 2.5 2.3 N N
089630 MIC16 5.1 (0.24) 7.2 (0.07) 6.7 (0.05) 5.9 (0.18) 5.1 (0.12) 4.8 - 3.1 1.9 3.2 N Y
115730 AMA1-paralogue
[SporoAMA1]
3.8 (0.13) 6.1 (0.25) 5.1 (0.03) 3.6 (0.28) 3.6 (0.01) 3.2 [2.0] 1.6 1.7 1.7 Y N
091890 MIC1 5.0 (0.26) 8.6 (0.05) 8.6 (0.11) 8.3 (0.06) 5.7 (0.11) 17.4 - 18.5 - 12.9 Y Y
014940 M2AP 5.4 (0.51) 8.4 (0.12) 8.4 (0.09) 8.0 (0.18) 6.6 (0.05) 12.5 - 12.5 - 5.5 Y Y
119560 MIC3 5.7 (0.20) 9.5 (0.10) 9.2 (0.07) 8.8 (0.08) 7.7 (0.10) 30.5 - 23.5 - 4.5 Y Y
001780 MIC2 5.6 (0.31) 7.3 (0.31) 7.8 (0.13) 7.8 (0.05) 6.0 (0.02) 3.9 - 5.9 - 4.4 Y Y
077080 MIC5 5.1 (0.31) 8.7 (0.31) 8.4 (0.03) 8.4 (0.05) 7.0 (0.03) 19.9 - 14.6 - 3.6 N Y
055260 AMA1 4.8 (0.30) 7.5 (0.07) 7.3 (0.01) 7.1 (0.12) 6.1 (0.04) 7.4 - 6.2 - 2.7 Y Y
008030 MIC4 4.1 (0.04) 6.4 (0.54) 6.9 (0.01) 7.3 (0.07) 6.5 (0.14) 3.7 - 5.5 - - Y Y
008740 microneme
protein, putative
4.3 (0.10) 4.3 (0.48) 4.2 (0.26) 6.6 (0.12) 7.5 (0.11) - - - [4.1] [9.1] N Y
Mean normalized, glog-transformed expression values and calculated fold-change in expression levels for each pair-wise comparison. The standard error of the mean
(SEM) is given in parentheses.
1TGME49_Gene identifier according to ToxoDB.org (v6.4).
2Identity of protein assigned by ToxoDB.org (v6.4).
3Oocysts sporulated for 0, 4 or 10 days.
4in vitro-derived tachyzoites (2 dpi).
5in vivo-derived bradyzoites (21 dpi).
6Detection in day 10 (mature) oocyst proteome. Yes (Y) indicates that a minimum of 2 unique peptides mapping to given protein were identified by mass spectrometry.
7Previous mass spectrometry evidence of expression in tachyzoites according to ToxoDB.org (v6.4).
*Fold change calculated from glog mean expression values back transformed to the original scale (see materials and methods) and shown only where values are
significantly different, p,0.05.
doi:10.1371/journal.pone.0029998.t005
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would appear that the RON4L1 paralogue is not participating in
the novel, sporozoite-specific MJ pairing with SporoRON2 and
SporoAMA1 and that the rest of the MJ machinery (RON4/5/8)
is also unvarying. Whether the SporoRON2/SporoAMA1 pair
functions independently of the other RONs or in complex with
them, like the normal RON2/AMA1 pair, is an important
question for further investigation.
Dense granule proteins (GRAs) are secreted towards the end of
parasite entry into the host cell and likely serve a role in
maintenance of the parasite’s intracellular niche within the
parasitophorous vacuole, though their function is generally not
well understood [60–62]. GRAs that have previously been
identified in oocysts based on antibody detection include GRA1,
GRA2, GRA4, GRA5, GRA6, GRA7 and GRA8 [21]. In this
study, RNA levels for GRA1–8 and GRA14 increased in oocysts as
they matured. Consistent with previous studies, GRA3 and NTPase
expression in d10 oocysts remained significantly lower than in
both bradyzoites and tachyzoites [63]. GRA8 expression was
significantly higher in d10 oocysts compared to bradyzoites and
did not differ significantly from tachyzoite levels. GRA14
expression was significantly higher in d10 oocysts than in both
tachyzoites and bradyzoites (Table 7). As before, the proteomic
data strongly corroborated these results with all the above GRAs
detected in tachyzoites and all but the three with glog expression
values below 7 (GRA3, GRA9 and NTPaseI) detected in d10
oocysts.
Antioxidant systems
Toxoplasma possesses a number of enzymes associated with
detoxification of reactive oxygen species, such as superoxide
dismutase (SOD), catalase, glutathione peroxidase, glutaredoxin,
glutathione/thioredoxin peroxidase and peroxiredoxin [48].
Table 6. Functionally interesting genes of Toxoplasma gondii oocysts at different stages of maturation with a comparison to
bradyzoite and tachyzoite expression levels - rhoptry proteins**.
Mean glog expression (SEM) Fold Change* [fold change lower] Proteomic evidence
Gene
ID1 Product2 d03 d43 d103 Tz4 Bz5
d4 vs.
d0
d10 vs.
d4
d10 vs.
d0
d10 vs.
Tz
d10 vs.
Bz Oo6 Tz7
009980 ROP42 4.6 (0.36) 7.9 (0.58) 7.2 (0.13) 3.8 (0.06) 7.6 (0.20) 11.8 - 6.1 7.9 - Y Y
114250 BRP1 5.1 (0.20) 8.4 (0.78) 7.7 (0.10) 5.0 (0.17) 8.8 (0.06) 14.9 - 7.2 7.8 - N N
014080 Toxofilin 5.6 (0.02) 8.6 (0.67) 8.3 (0.01) 6.6 (0.04) 8.8 (0.12) 12.9 - 9.8 4.5 - Y Y
030470 ROP46, putative 4.7 (0.22) 7.9 (0.18) 6.7 (0.01) 5.1 (0.20) 5.6 (0.03) 10.8 [2.9] 3.7 3.1 2.2 N N
058370 ROP28 4.5 (0.06) 6.7 (0.36) 5.9 (0.00) 3.5 (0.08) 6.8 (0.22) 4.1 - 2.3 3.0 - Y N
108080 ROP5 4.7 (0.16) 8.5 (0.40) 7.8 (0.02) 6.7 (0.09) 5.5 (0.16) 20.0 - 9.7 2.7 6.5 Y Y
065120 RON2L2
[Sporo-RON2]
3.7 (0.21) 6.2 (0.42) 5.5 (0.02) 3.4 (0.01) 3.7 (0.02) 3.6 - 2.1 2.3 2.1 Y N
027810 ROP11 4.8 (0.14) 8.2 (0.57) 7.2 (0.04) 7.3 (0.01) 5.9 (0.08) 14.3 - 5.5 - 3.0 Y Y
042110 ROP38 (ROP2L5) 4.7 (0.14) 6.0 (0.45) 6.5 (0.03) 6.0 (0.12) 5.1 (0.14) 2.1 - 3.2 - 2.6 N N
015780 ROP2A (ROP2) 5.2 (0.19) 8.2 (0.58) 7.5 (0.12) 8.3 (0.02) 7.4 (0.17) 11.3 - 5.8 - - Y Y
005250 ROP18 5.0 (0.39) 7.8 (0.52) 7.2 (0.09) 7.2 (0.10) 6.3 (0.15) 9.1 - 5.2 - - Y Y
106060 RON8 5.6 (0.32) 7.7 (0.53) 7.0 (0.09) 7.2 (0.02) 6.5 (0.09) 5.4 - 3.0 - - Y Y
115220 ROP14 4.4 (0.21) 6.5 (0.59) 6.2 (0.18) 6.4 (0.15) 6.3 (0.13) 3.5 - 2.8 - - Y Y
109590 ROP1 4.5 (0.34) 6.7 (0.46) 6.2 (0.22) 7.4 (0.03) 5.5 (0.15) 3.9 - 2.6 - - Y Y
058660 ROP6 4.8 (0.42) 7.0 (0.51) 6.3 (0.01) 6.9 (0.04) 6.1 (0.20) 4.7 - 2.5 - - Y Y
011260 ROP26 4.8 (0.41) 6.2 (0.40) 5.9 (0.08) 7.0 (0.01) 7.5 (0.18) 2.3 - - - [3.8] N Y
015770 ROP8 4.0 (0.04) 4.2 (0.67) 3.7 (0.04) 4.3 (0.12) 7.2 (0.12) - - - - [7.8] N Y
003990 ROP12 4.5 (0.13) 6.4 (0.37) 5.4 (0.04) 6.5 (0.01) 6.1 (0.25) 3.2 - - [2.3] - Y Y
058580 ROP17 4.9 (0.14) 7.0 (0.34) 6.4 (0.04) 7.5 (0.01) 6.7 (0.01) 4.3 - 2.7 [2.5] - Y Y
053330 Rhoptry
kinase family
3.9 (0.13) 2.8 (0.17) 2.9 (0.11) 5.8 (0.07) 8.3 (0.02) [1.3] - [1.3] [3.1] [25.6] N Y
062050 ROP39 4.0 (0.17) 4.4 (0.22) 3.7 (0.03) 6.1 (0.03) 4.6 (0.20) - - - [3.2] [1.3] N Y
042240 ROP19 4.0 (0.21) 5.2 (0.00) 4.6 (0.19) 7.2 (0.11) 5.0 (0.44) - - - [6.0] - N N
Mean normalized, glog-transformed expression values and calculated fold-change in expression levels for each pair-wise comparison. The standard error of the mean
(SEM) is given in parentheses.
1TGME49_Gene identifier according to ToxoDB.org (v6.4).
2Identity of protein assigned by ToxoDB.org (v6.4).
3Oocysts sporulated for 0, 4 or 10 days.
4in vitro-derived tachyzoites (2 dpi).
5in vivo-derived bradyzoites (21 dpi).
6Detection in day 10 (mature) oocyst proteome. Yes (Y) indicates that a minimum of 2 unique peptides mapping to given protein were identified by mass spectrometry.
7Previous mass spectrometry evidence of expression in tachyzoites according to ToxoDB.org (v6.4).
*Fold change calculated from glog mean expression values back transformed to the original scale (see materials and methods) and shown only where values are
significantly different, p,0.05.
**Rhoptry designation confirmed or putatively designated without confirmation of localization.
doi:10.1371/journal.pone.0029998.t006
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Glutaredoxin and superoxide dismutase (SOD3) were included in
the top 30 genes most abundantly expressed at the RNA level in
d10 oocysts compared to tachyzoites and bradyzoites (Table 3);
both have been shown previously to be present in sporulated
oocysts [48] and both were detected in the d10 oocyst but not
tachyzoite proteomes. In addition to the antioxidant enzymes,
RNA corresponding to an oxidoreductase family protein, alanine
dehydrogenase (TGME49_115260), was uniquely abundant in
d10 oocysts compared to tachyzoites and bradyzoites with
corresponding proteomic data to match (present in d10 oocysts
but not tachyzoites; Table 3).
Putative oocyst wall components
The wall compositions of two Apicomplexan genera, Eimeria and
Cryptosporidium, have been partially characterized and serve as models
for wall composition in Toxoplasma. In Eimeria, the oocyst wall is
composed of proteins that are rich in tyrosine and undergo tyrosine-
protein crosslinkages, providing structural robustness and resulting in
the characteristic autofluorescence when exposed to UV light [64].
The genes for six tyrosine-rich proteins were markedly up regulated
in the d10 oocysts compared to tachyzoites and bradyzoites where
they appeared essentially off (with glog expression values generally
below 5; Table 8). Interestingly, two of the tyrosine-rich proteins
(TGME49_037080 and TGME49_087250) had peak expression
levels in d0 oocysts as might be expected for proteins that are
structural components of the oocyst wall. Expression of the
remaining four tyrosine-rich genes peaked in d4 oocysts at the time
the sporocyst walls are forming, suggesting that they may be being
incorporated into the walls of the sporocysts, which are also
autofluorescent and therefore might also contain dityrosine-protein
crosslinkages as has been proposed for oocyst walls. All six of these
tyrosine-rich proteins were detected in our proteomic analysis of
oocysts. The two with the highest levels of expression observed in d0
oocysts were also enriched in the wall fractions, (TGME49_037080
and TGME49_087250), suggesting they are a part of the wall and
not the sporocysts or sporozoites within. These tyrosine-rich proteins
and their putative locations are described in more detail in the
accompanying manuscript.
Unlike Eimeria and Toxoplasma, Cryptosporidium oocyst walls do
not autofluoresce and have a cysteine-rich wall that is thought to
be strengthened by disulfide cross-linkages between the OWPs
[65]. Six of the seven TgOWP homologues have corresponding
probesets on the T. gondii array. In addition to the two discussed
above (TgOWP2 and 5), all four of the remaining COWP
homologues (TgOWP1, 3, 4 and 7) had significantly higher
expression levels in d10 oocysts compared to both tachyzoites and
bradyzoites (Table 8). Interestingly, however, only one of these
proteins was detected in the proteomic analysis of d10 oocysts
(TgOWP2) and a different one (TgOWP3) was detected in the
tachyzoite proteome (Table 8), although this latter protein was
found in only one of the five tachyzoite proteomic analyses and
only two peptides were seen. TgOWP1, TgOWP2 and TgOWP3
have, however, all previously been detected using antibody
reagents in Toxoplasma oocysts [45].
Discussion
The results described here provide much information about the
genes involved in oocyst development from the initial, relatively
amorphous, immature form to the mature entity with its eight fully
formed sporozoites. Several genes’ transcripts were found to be
most abundant in ‘‘d0’’ oocysts compared to later oocyst stages,
tachyzoites and bradyzoites. These genes likely function in early
Table 7. Functionally interesting genes of Toxoplasma gondii at different stages of oocyst maturation with a comparison to
bradyzoite and tachyzoite expression levels - dense granules.
Mean glog expression (SEM) Fold-change* [fold-change lower] Proteomic evidence
Gene
ID1 Product2 d03 d43 d103 Tz4 Bz5
d4 vs.
d0
d10 vs.
d4
d10 vs.
d0
d10 vs.
Tz
d10 vs.
Bz Oo6 Tz7
039740 GRA14 5.2 (0.01) 9.3 (0.02) 8.9 (0.02) 7.6 (0.05) 6.8 (0.06) 33.6 [1.6] 21.7 3.4 6.7 Y Y
075440 GRA6 4.8 (0.13) 8.1 (0.12) 8.3 (0.07) 7.8 (0.03) 7.1 (0.08) 12.2 - 15.3 1.7 3.0 Y Y
054720 GRA8 4.8 (0.37) 8.6 (0.24) 8.9 (0.06) 8.3 (0.06) 5.7 (0.10) 20.1 - 27.2 - 15.9 Y Y
003310 GRA7 4.9 (0.38) 9.5 (0.06) 9.6 (0.09) 8.7 (0.09) 8.2 (0.17) 45.9 - 53.4 - 4.0 Y Y
110780 GRA4 4.8 (0.37) 6.8 (0.37) 7.1 (0.08) 7.0 (0.10) 5.9 (0.04) 3.9 - 5.1 - 2.8 Y Y
070250 GRA1 5.3 (0.26) 10.0 (0.06) 9.7 (0.08) 9.1 (0.03) 9.3 (0.02) 61.2 - 46.9 - - Y Y
086450 GRA5 5.5 (0.29) 9.6 (0.09) 9.5 (0.08) 9.1 (0.04) 9.3 (0.08) 35.6 - 32.9 - - Y Y
027620 GRA2 4.8 (0.19) 8.3 (0.10) 8.3 (0.04) 9.2 (0.02) 8.8 (0.02) 14.6 - 15.5 [2.5] - Y Y
027280 GRA3 5.0 (0.29) 5.2 (0.49) 6.7 (0.06) 8.3 (0.05) 8.1 (0.06) - 2.9 3.2 [4.3] [3.8] N Y
051540 GRA9 4.5 (0.23) 3.8 (0.03) 4.2 (0.06) 5.4 (0.03) 6.6 (0.05) [1.3] - - [1.7] [4.3] N Y
077240 NTPaseI 4.0 (0.14) 4.0 (0.05) 4.2 (0.02) 7.6 (0.11) 4.7 (0.12) - - - [9.5] - N Y
Mean normalized, glog-transformed expression values and calculated fold-change in expression levels for each pair-wise comparison. The standard error of the mean
(SEM) is given in parentheses.
1TGME49_Gene identifier according to ToxoDB.org (v6.4).
2Identity of protein assigned by ToxoDB.org (v6.4).
3Oocysts sporulated for 0, 4 or 10 days.
4in vitro-derived tachyzoites (2 dpi).
5in vivo-derived bradyzoites (21 dpi).
6Detection in day 10 (mature) oocyst proteome. Yes (Y) indicates that a minimum of 2 unique peptides mapping to given protein were identified by mass spectrometry.
7Previous mass spectrometry evidence of expression in tachyzoites according to ToxoDB.org (v6.4).
*Fold-change calculated from glog mean expression values back transformed to the original scale (see materials and methods) and shown only where values are
significantly different, p,0.05.
doi:10.1371/journal.pone.0029998.t007
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oocyst development and initial sporozoite formation. Some,
however, may represent genes that were involved in prior
development within the feline enterocyte where the oocyst begins
life; in these latter cases, the RNA detected may be residual. It is
important to remember, in this context, that the sort of microarray
analyses used here measure RNA abundance not transcription per
se and so there can be a lag between detecting a given gene’s
transcripts and the actual time when that gene was being actively
transcribed. Similarly, the ‘‘d0’’ sample was collected from feces
on the first day that a substantial oocyst load was detected. These
feces may have been shed up to 24 hours prior to the time when
they were collected (the feces were collected at the same time each
day). Hence, the very first few hours after initial shedding may not
have been captured and some significant changes in the
transcriptome may have occurred subsequent to the feces first
emerging (e.g., due to changes in temperature and exposure to air).
Among the genes most abundantly expressed by d0 oocysts were
two meiotic recombination genes encoding a DMC-like protein
and a putative SP011. DMC and SP011 homologues are required
for meiotic homologous recombination through chromosome
alignment and double-strand breaks [66]. The precise sequencing
of the steps in meiosis in Toxoplasma oocysts has not yet been
explored but these data suggest the process is far from finished
when oocysts are first shed. Transcripts for two scavenger receptor
proteins (TgSR1 and SR2) and an LCCL-domain-containing
protein (LCCL refers to Limulus clotting factor C, Coch-5b2, Lgl1
domain [67]) were uniquely abundant in d0 oocysts. In Plasmodium
berghei the scavenger receptor protein PbSR is synthesized by
macrogametes and is critical to sporogony; sporozoites fail to form
in the oocysts of PbSR knockout parasites [68,69]. Further, PbSR
is a member of a family of LCCL proteins in P. berghei that appear
to be structural paralogues involved in sporozoite development
Table 8. Functionally interesting genes of Toxoplasma gondii oocysts at different stages of maturation with a comparison to
bradyzoite and tachyzoite expression levels - other proteins of interest.
Mean glog expression (SEM) Fold-change* [fold-change lower]
Proteomic
evidence
Gene ID1 Product2 d03 d43 d103 Tz4 Bz5
d4
vs. d0
d10
vs. d4
d10
vs. d0
d10
vs. Tz
d10
vs. Bz Oo6 Tz7
Tyrosine-rich proteins (% tyrosine)
037080 hypothetical
protein (6.2%)
11.2 (0.52) 9.6 (0.35) 9.7 (0.05) 3.6 (0.22) 3.7 (0.03) - - - 90.9 84.6 Y N
120530 hypothetical
protein (5.6%)
6.3 (0.13) 9.9 (0.15) 9.4 (0.07) 3.3 (0.20) 3.6 (0.20) 29.1 - 18.2 76.9 69.7 Y N
081590 hypothetical
protein (15.5%)
5.9 (0.01) 10.6 (0.07) 9.9 (0.08) 4.9 (0.04) 4.6 (0.28) 81.2 [2.15] 37.7 66.7 77.6 Y N
087250 hypothetical
protein (13.5%)
11.0 (0.44) 8.6 (0.73) 9.1 (0.02) 4.3 (0.01) 3.6 (0.09) [10.6] - [6.3] 41.7 50.7 Y N
119890 hypothetical
protein (5.5%)
4.7 (0.29) 10.3 (0.04) 9.3 (0.04) 5.6 (0.13) 4.2 (0.04) 114.8 [2.78] 41.3 26.3 51.2 Y N
116550 hypothetical
protein (19.5%)
3.9 (0.12) 9.7 (0.04) 7.8 (0.13) 3.6 (0.13) 3.9 (0.14) 87.0 [6.77] 12.9 13.7 12.6 Y N
Putative oocyst wall proteins
004420 TgOWP1 5.1 (0.17) 7.4 (0.58) 7.4 (0.05) 4.3 (0.14) 5.0 (0.01) 5.5 - 5.6 8.2 56.0 N N
009610 TgOWP2 10.7 (0.44) 8.4 (0.74) 8.8 (0.02) 3.3 (0.19) 3.9 (0.13) [10.2] - [7.0] 38.5 34.0 Y N
068310 TgOWP3 4.5 (0.02) 5.9 (0.47) 5.6 (0.00) 3.6 (0.08) 4.4 (0.15) 2.3 - - 2.3 1.8 N Y
022940 TgOWP4 4.4 (0.03) 6.7 (0.29) 5.9 (0.03) 4.8 (0.05) 4.5 (0.07) 4.3 [1.96] 2.20 1.9 2.1 N N
048730 TgOWP5 5.4 (0.07) 7.6 (0.49) 7.5 (0.04) 3.9 (0.12) 4.6 (0.07) 6.2 - 5.44 10.0 7.8 N N
010950 TgOWP7 3.7 (0.23) 5.8 (0.51) 5.6 (0.16) 3.5 (0.04) 3.7 (0.03) 2.5 - 2.35 2.5 2.3 N N
Late embryogenesis abundant domain-containing proteins (LEAs)
076850 LEA (TgERP) 4.9 (0.07) 10.4 (0.14) 9.4 (0.02) 3.5 (0.31) 4.4 (0.05) 110.7 - 44.7 71.4 55.4 Y N
076880 LEA 4.3 (0.13) 10.2 (0.14) 9.3 (0.02) 3.5 (0.03) 3.8 (0.04) 123.7 [2.39] 51.7 66.7 60.0 Y N
076860 LEA 4.1 (0.23) 9.3 (0.30) 8.0 (0.10) 3.3 (0.23) 3.8 (0.09) 52.2 [3.43] 15.2 18.9 16.4 Y N
076870 LEA1 protein,
putative
5.8 (0.46) 9.3 (0.06) 7.6 (0.02) 3.4 (0.09) 4.0 (0.24) 23.4 [5.47] 4.3 11.9 10.4 Y N
Mean normalized, glog-transformed expression values and calculated fold-change in expression levels for each pair-wise comparison. The standard error of the mean
(SEM) is given in parentheses.
1TGME49_Gene identifier according to ToxoDB.org (v6.4).
2Identity of protein assigned by ToxoDB.org (v6.4).
3Oocysts sporulated for 0, 4 or 10 days.
4in vitro-derived tachyzoites (2 dpi).
5in vivo-derived bradyzoites (21 dpi).
6Detection in day 10 (mature) oocyst proteome. Yes (Y) indicates that a minimum of 2 unique peptides mapping to given protein were identified by mass spectrometry.
7Previous mass spectrometry evidence of expression in tachyzoites according to ToxoDB.org (v6.4).
*Fold change calculated from glog mean expression values back transformed to the original scale (see materials and methods) and shown only where values are
significantly different, p,0.05.
doi:10.1371/journal.pone.0029998.t008
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and infectivity. A putative major facilitator protein that has
conserved regions with the Major Facilitator Superfamily (MFS),
based on BLAST analysis of the predicted amino acid sequence,
was up-regulated in d0 oocysts. The MFS comprises a diverse
group of proteins, with at least 17 distinct families, generally
involved in transport (uniport, symport or antiport) of small solutes
in response to chemiosmotic gradients [70,71]. A wide range of
functions has been described for MFS proteins, including uptake
of sugars [71] and efflux of drugs and metabolites [72]. Another
gene with specifically elevated levels in the d0 oocyst is C-protein
immunoglobulin A (IgA)-binding beta antigen. IgA-binding
proteins have been described in pathogenic bacteria including
group B Streptococcus where they are expressed as surface proteins
that bind the Fc portion of human IgA and prevent their
interactions with Fc receptors [73], thereby interfering with the
effector function of host IgA [74]. IgA is critical to effective
mucosal immune responses in the gut where it serves as a first line
of defense against pathogens at mucosal surfaces [75]. It is possible
that the C-protein IgA-binding beta antigen protein plays a role in
mitigating host cell responses to the oocysts that are emerging from
the feline enterocytes into the gut lumen for excretion into the
environment. Alternatively, this protein’s role might be in the gut
of the intermediate host in which the sporozoites are initiating a
new infection. Arguing against this latter notion is that this gene’s
expression declines later in oocyst development, when sporozoites
are being actively generated.
Among the more interesting trends that emerged from our
analyses of a time course of oocyst development is the remarkable
predominance of ribosomal protein genes in the list of most up-
regulated genes in d10 versus d4 oocysts (Fig. 2 and Table S3).
While some ribosomal proteins are encoded by two or more
paralogous genes, there was no trend for the genes observed as up-
regulated to be paralogues of genes that were correspondingly
down-regulated over the same time period. That is, there did not
seem to be a d10 oocyst-specific set of ribosomal proteins that
replaced a paralogous set expressed earlier. Instead it would seem
that d10 oocysts are up-regulating ribosomal protein genes in
general, perhaps to build a stock of ribosomes for the long period
most oocysts must spend in the environment before being ingested.
This store of ribosomes might enable an oocyst that suddenly finds
itself in an intermediate host’s intestine, after months or years of
relative dormancy in the environment, to rapidly restart
translation and development in order to launch a new infection.
The predominance of genes encoding secreted proteins among
the set that is up-regulated in d4 and 10 oocysts, relative to d0,
likely corresponds to the need for stocking the many secretory
organelles that must be made, de novo, in the nascent sporozoites
(rhoptries and micronemes, at least, are not recognizably present
in the immature oocyst). The final, mature sporozoite must have a
full complement of such proteins ready for the time when they
encounter a new host and must invade. It is interesting that genes
encoding several of the ROP proteins that are known to play a key
role in co-opting host functions upon invasion by tachyzoites
(ROP5, ROP16 and ROP18) are amply expressed in mature
oocysts/sporozoites. This suggests that these protein kinases and
pseudokinases may serve a similar function for the invading
sporozoite as they do for the tachyzoites in which they were first
discovered [76,77]. A few ROP genes, e.g., ROP42, are
substantially up-regulated in d10 oocysts relative to tachyzoites
(although they are expressed in the latter at a low level). The
proteins encoded by these genes may meet a special challenge for
the invading sporozoite that tachyzoites do not face, perhaps
related to invasion of gut epithelia which tachyzoites would not
normally have an opportunity to invade. Interestingly, ROP42 is
also highly expressed at the RNA level in bradyzoites, consistent
with a possible role for ROP42 in establishing an early infection in
the gut since bradyzoites too must invade this tissue in order to
start a new infection.
The function of the SRS family of surface proteins is largely
unknown despite being one of if not the largest gene families in
Toxoplasma (over 150 paralogous genes are present in the RH strain
genome; [43]). The founding member of this family, SAG1, has
been implicated in attachment of parasites to a host cell [78] and
in somehow impacting the inflammatory response to the infection
[79] but this does little to explain the pressures leading to the
enormous gene expansion of this gene family. Genes for two SRS
proteins were found to be strongly up-regulated in d10 oocysts
relative to all other datasets in our analysis, the previously
described ‘‘SporoSAG’’ and the gene encoding one of the original
SRS proteins to be identified in tachyzoites and an important
player in tachyzoite-mediated infection in mice, SAG3 [80]. Given
their purported importance in the early stages of host cell invasion
[81], it might have been expected that sporozoites and bradyzoites
would share more similarity in their surface antigen repertoire (i.e.,
since they share a common gastrointestinal route of infection and
therefore might encounter similar host cell receptors). It was
surprising, therefore, that the opposite was seen: the oocysts more
closely resembled tachyzoites than bradyzoites in their pattern of
SRS gene expression. This added information about stage-
specificity of their expression provides further clues to the still
enigmatic function of SRS proteins.
One of the most striking findings in this work was the oocyst-
specific expression of paralogues of AMA1 and RON2. AMA1 is
expressed on the surface of tachyzoites where it binds to RON2 on
the host cell surface; RON2 is injected into a host cell as one of the
first steps in invasion and the parasite thereby provides its own
receptor for attachment [54–56]. The fact that there are ‘‘Sporo’’
versions of these two key proteins suggests that they again meet a
special need of sporozoites. Interestingly, neither protein has ever
been detected within tachyzoites and the corresponding transcripts
are likewise seemingly not expressed in tachyzoites and bradyzoites
(there are no publicly available proteomic datasets for the latter
stage). Whether this novel pair of proteins functions at the moving
junction of sporozoites, or perhaps serves some new role, will be
technically challenging to demonstrate as engineering parasites
that express tagged versions of proteins and that can still go
through the entire life cycle of Toxoplasma has never been reported.
Unfortunately, an approach using polyclonal antibodies to these
proteins is also likely to be problematic as these are likely to cross-
react with their respective paralogues, which were also detected in
the sporozoites. The final challenge will be catching a sporozoite
mid-way during invasion, which is the only time that the moving
junction exists; it is difficult to efficiently release sporozoites and
follow their subsequent infection en masse. Such work will be
important to attempt, however, as the original AMA1/RON2
pairing, at least, serves such a pivotal role in tachyzoites and this
new pair seems likely to be serving an equally interesting and
important role in sporozoites.
Once fully mature, the oocyst is generally considered to be inert
and to exist in a dormant state in the environment until ingested
by a susceptible intermediate host. Presumably it must therefore
persist with its limited stores of energy such as the amylopectin
granules that are present in the sporozoites [82]. Our data do not
address what the transcriptome would look like in an oocyst that
has persisted in the environment or under laboratory storage
conditions for prolonged periods of time such as months or years.
Such information will come from analysis of oocysts stored in
conditions that mimic the natural environment (e.g., soil or water).
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Overall, the data presented here, however, present a detailed
insight into the development of a previously mysterious stage in the
Toxoplasma life cycle. They reveal a number of important
differences from the asexual stages that are likely key to the
unique role for this developmental form.
Materials and Methods
Ethics statement
All kitten and mouse experiments were conducted conforming
to the guidelines of the Animal Welfare Act and the Health and
Research Extension Act. Experimental protocols were approved
by the UC Davis Institutional Animal Care and Use Committee,
which is accredited by the Association for Assessment and
Accreditation of Laboratory Animal Care International (IACUC
#15619). Efforts were made to minimize the numbers of animals
used to generate Toxoplasma organisms. The kittens used in the
study remained healthy throughout. After two weeks of confirmed
absence of shedding of Toxoplasma oocysts, the kittens were
vaccinated and neutered, then adopted out to pre-screened and
approved permanent homes.
Toxoplasma gondii oocyst production
Mouse Infection. Initial mouse infections were done using
Toxoplasma gondii oocysts produced in kittens in our laboratory
using previously described methods [83]. The oocysts were from
the M4 strain of T. gondii, isolated from an aborted sheep fetus and
donated to our laboratory by the Moredun Research Institute of
Scotland. Twenty 10-week old female Swiss Webster mice
(Charles River Laboratories, Wilmington, MA) were inoculated
subcutaneously (SQ) with 1,000 Toxoplasma gondii oocysts
suspended in 200 ml phosphate buffered saline (PBS). One of the
mice was given brain homogenate from a previously infected
mouse, in addition to the oocysts SQ and a second mouse was
given 1,000 oocysts per os (PO) by gastric gavage, in addition to the
SQ oocyst inoculum. Mice were bled every two weeks, beginning 3
weeks after inoculation, to monitor T. gondii titers. At 6 weeks post-
infection (wpi) 3 mice were euthanized for evaluation of bradyzoite
brain cyst formation by histology. Eight weeks after infection 10
mice were sacrificed and their brains collected. Half of each brain
was fed to the kittens and the other half was submitted for
histology for verification of status and rate of infection.
Kitten Infection. To produce oocysts for these experiments
two 12-week-old specific-pathogen-free kittens (Nutrition and Pet
Care Center, Department of Molecular Biosciences, University of
California, Davis) were infected by feeding a total of 2.5 mouse
brains each (half of 5 brains each, as above). An indirect
fluorescent-antibody test (IFAT) was performed to ensure that
they were seronegative for Toxoplasma gondii antibodies prior to
infection.
Oocyst Harvest from Kitten Feces. Feces were collected
from kittens daily and examined by zinc sulfate double
centrifugation to detect shedding of oocysts as well as monitor
for co-infection with other parasites. Kittens were shedding
Cryptosporidium oocysts prior to infection with T. gondii. However,
Cryptosporidium oocysts were not detected after shedding of T. gondii
oocysts commenced. No other protozoal organisms were observed.
Once T. gondii oocysts were detected in feces, all procedures were
conducted in a biohazard hood and unsporulated oocysts were
harvested from feces using sodium chloride (specific gravity 1.20)
to concentrate the oocysts by flotation. Following the final wash
step, the resultant oocyst pellet was resuspended in approximately
12 ml of 2% sulfuric acid and transferred to a T75 tissue culture
flask for sporulation. Oocysts were incubated and aerated by
gentle rocking for a defined period (4 days or 10 days) at room
temperature (,22uC) to allow for sporulation. Day 0 oocysts (0%
sporulated) were collected prior to aeration in sulfuric acid and
directly purified.
Oocyst Purification. Prior to purification, oocysts were
washed three times in PBS to remove sulfuric acid and restore
neutral pH. Gradient separation was performed with CsCl in Tris-
EDTA buffer (TE buffer), layering CsCl at specific gravities of
1.15, 1.10, 1.05 and oocysts in TE buffer as top layer, as previously
described [84]. The specific gravity of T. gondii oocysts is between
1.05–1.10. Gradient preparations were performed in 50 ml
polypropylene tubes. Samples were centrifuged at 16,0006 g for
60 min. Oocysts were harvested at the 1.05/1.10 interface. The
harvested layers were washed twice with PBS, using spins at
25006 g for 15 min each. The final pellet was resuspended in
PBS.
RNA from oocysts, tachyzoites and bradyzoites
Oocyst preparation for RNA extraction. 56106 oocysts
were harvested at each duplicate time point, suspended in 125 mL
PBS and stored at 280uC until extracted. Upon extraction, frozen
oocysts were re-suspended in 1 ml TRIzol (Invitrogen). After
loading 1 ml TRIzol into the chamber of a pre-cooled (280uC)
French Pressure Cell (Thermo Electron Aminco French Pressure
Cell, Model FA-003), the 1 ml oocyst suspension was added to the
pressure cell chamber. The resulting 2 ml volume was pressed at
20,000 p.s.i. and a roughly 1.5 ml fraction was collected. Note: It
was determined that approximately 0.5 ml was lost in the pressure
cell, therefore 1 ml TRIzol was preloaded to occupy the dead
space volume that would not be recovered. The pressure cell was
sterilized between each sample by autoclaving then washing with
Milli-Q water.
Tachyzoite preparation for RNA extraction. Tachyzoites
of the same M4 isolate were grown in confluent monolayers of
primary human foreskin fibroblasts (HFF) in DMEM (Invitrogen,
Carlsbad, CA) with 10% fetal calf serum (FCS; Hyclone, Logan,
UT), 2 mM glutamine, 100 U/ml and 100 ug/ml streptomycin at
37uC with 5% CO2. In vitro 2 dpi tachyzoite samples were
collected from separately infected cultures of HFFs (replicate flasks
were infected in parallel with an MOI of 3). Samples were
harvested separately and processed independently for all steps. To
isolate the parasites, HFFs were lysed by passage through a 27-
gauge needle at least 10 times. Whole cells were pelleted by brief
centrifugation (,3 minutes) in a Sorvall RT7 plus tabletop
centrifuge at 700 rpm (1026 g). The parasites were collected by
centrifugation of the supernatant at 1500 rpm (4706 g) for
10 minutes. Parasites were then brought up in 1 ml TRIzol
reagent (Invitrogen) and frozen at 280uC.
Bradyzoite cyst preparation for RNA extraction. Bra-
dyzoite cysts were produced and isolated as previously described
[83]. For biologic duplicates, two separate groups of four 8-week-old
SwissWebster mice were infected with 1,000 oocysts PO. One mouse
in the first group was infected with 1,000 oocysts SQ. To minimize
morbidity and prevent death in infected mice, all infected mice were
treated with sulfadiazene (0.4 mg/ml in drinking water) for 10 days,
beginning 10 days post-inoculation. Three weeks post-inoculation
mice were sacrificed and brains were harvested.
The methods used to isolate bradyzoite cysts from mouse brains
were modified from a previously described protocol [85]. Each
brain was passed through a 100 mm cell strainer into a 50 ml
conical tube using the plunger of a 6 ml syringe to press the tissue
through the strainer and washing with PBS to a total volume of
4 ml. The brain suspension was then syringe-passed through a 16
gauge blunt needle 10 times followed by a 22 gauge blunt needle
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10 times. The brain suspension was brought up to a total volume
of 10 ml with PBS. A density gradient was prepared for each
sample by carefully layering (from bottom to top) 9 ml 90%
Percoll, followed 9 ml 30% Percoll, then 10 ml brain suspension in
a 50 ml conical tube. Percoll dilutions were made using 16PBS.
Each gradient was centrifuged at 1,2006g for 15 minutes at 4uC.
Cysts were harvested from the 30% and 30%/90% interface. Cyst
suspensions were washed with 45 ml PBS and centrifuging at
1,5006 g for 15 min at 4uC. The supernatant was removed to
about 5 ml and the pellets were combined into one 50 ml tube. A
second wash in PBS was performed by bringing the combined
suspension up to 45 ml with PBS and centrifuging at 2,5006g for
15 minutes at 4uC. The supernatant was removed and the
remaining pellet was transferred to a 1.5 ml microcentrifuge tube
and brought up to 1 ml with PBS. A 10 ml aliquot was removed for
cyst enumeration. The suspension was then centrifuged at
13,200 rpm for 8 minutes and the supernatant was removed.
Cysts were counted by removing 10 ml of final cyst suspension to a
glass slide with a coverslip. The entire area under the converslip
was counted and the total estimated cyst number calculated. The
final cyst pellet was resuspended in 1 ml TRIzol and stored at
280uC until RNA was extracted.
RNA Extraction and Microarray. RNA extraction
methods were adapted from Invitrogen TRIzol instructions for
RNA isolation, with a few modifications. Frozen samples were
thawed in a 37uC water bath and then allowed to equilibrate to
room temperature. 0.2 ml chloroform was added to TRIzol
suspensions. Tubes were mixed by hand for 15 seconds then
incubated for 3 minutes at room temperature. Tubes were then
spun at 12,000 rpm for 20 minutes at 4uC. The aqueous phase
containing the RNA was transferred into a fresh tube (,550 ml).
0.5 ml isopropyl alcohol was added. Tubes were mixed by hand
and incubated at room temperature for 10 minutes. Tubes were
then spun at 13,000 rpm for 20 minutes at 4uC. To wash the
RNA, supernatant was removed and 1 ml 75% ethanol was
added to pellet. Tubes were inverted to mix by hand. Tubes were
spun at 13,000 rpm for 20 minutes at 4uC. Supernatant was
removed and the RNA pellet was air-dried in open tube for
approximately 10 minutes. RNA was re-dissolved in 12 ml
RNase-free water.
RNA preparation for microarray was conducted using the
protocol and reagents provided in the Invitrogen Gene Chip
39IVT Express Kit. 250 ng of total RNA was used as the starting
material. Instructions for 169/400/HT format were followed for
fragmentation and labeling of aRNA.
Samples were hybridized to the Toxoplasma gondii Affymetrix
Array (Tgondiia520372) by the Stanford Protein and Nucleic Acid
Facility. The following equipment was used to scan the arrays and
generate. cel files: Affymetrix GeneChip Hybridization Oven 640,
Affymetrix GeneChip Fluidics Station 450, Affymetrix GeneChip
Scanner 3000 7G and Affymetrix Genechip Command Console
(AGCC). AGCC was used to generate and normalize gene
expression values.
Microarray Analysis
Preprocessing. Data were converted from. cel files and
averaged across probes within each probeset using the
Bioconductor package affy (version 1.22.1, [86]) within the
statistical software system R (version 2.10.1, [87]), and
transformed via a generalized logarithm transformation [34,88]
using Bioconductor package LMGene (version 2.4.0, [89]).
Statistical Analysis. A one-way analysis of variance
(ANOVA) model was fitted to the data one probeset at a time.
The ANOVA model included a single factor for time/lifestage,
with the following levels: Day 0 oocysts, Day 4 oocysts, Day 10
oocysts, tachyzoites, and bradyzoites. For probes for which the
global F test of a time/lifestage effect was significant at the 5%
level, indicating significant differences between at least two levels
of the factor, Tukey HSD post-hoc tests were conducted to test for
significant differences among the comparisons of interest (day 4
oocysts vs. day 0 oocysts, day 10 oocysts vs. day 4 oocysts, day 10
vs. day 0 oocysts, day 10 oocysts vs. tachyzoites, and day 10
oocysts vs. bradyzoites). For each of the above comparisons of
interest, the statistical analysis produced a list of probesets/
Toxoplasma gene IDs for which the expression levels differed
significantly (Tukey HSD p,0.05) between the times/lifestages
being compared, (due to the presence of controls, etc., not every
probeset had a corresponding gene ID). Fold changes were
calculated as follows: On the scale of the transformed data, the
mean expression was calculated for each stage/sample type of
interest (e.g. d0 oocyst). The mean for each was then transformed
back to the original scale of the data by inverting the glog
transformation, and the fold change was calculated as the ratio of
back-transformed means.
Data Deposition. All data is MIAME compliant and the raw
data have been deposited on the Gene Expression Omnibus
(GEO) site (www.ncbi.nlm.nih.gov/geo/), GEO accession
number: GSE32427. The complete searchable dataset is also
available at ToxoDB.org.
Supporting Information
Table S1 Percentiles for glog expression values across
dataset.
(DOCX)
Table S2 All probesets for which a significant difference
(p,0.05) was identified in any of the following pair-wise
comparisons: oocyst time points - d4 vs. d0, d10 vs. d0,
d10 vs. d4; and between oocysts and asexual lifestages -
d10 vs. tachyzoite (2 dpi), d10 vs. bradyzoite (21 dpi).
(XLSX)
Table S3 Lists of the top 30 significant genes (p,0.05)
in each of the oocyst time point comparisons, listed in
order of genes with the largest fold-change in mean
expression level in each direction, up or down.
(XLSX)
Table S4 Summary of RON2/AMA1 and SporoRON2/
SporoAMA1 expression across all samples.
(DOCX)
Acknowledgments
Thanks to Michael White and the members of his laboratory at the
University of South Florida for providing guidance, facilities and
equipment necessary to obtain high-quality RNA from oocysts. Thanks
to Ann Melli and Andrea Packham for their assistance with mouse
handling and oocyst production.
Author Contributions
Conceived and designed the experiments: HMF KRB PAC JCB.
Performed the experiments: HMF KRB. Analyzed the data: HMF XC
BDJ DMR. Contributed reagents/materials/analysis tools: PAC JCB.
Wrote the paper: HMF PAC JCB.
Toxoplasma gondii Oocyst Transcriptome
PLoS ONE | www.plosone.org 16 February 2012 | Volume 7 | Issue 2 | e29998
References
1. Frenkel JK (1990) Toxoplasmosis in human beings. J Am Vet Med Assoc 196:
240–248.
2. Jones J, Lopez A, Wilson M (2003) Congenital toxoplasmosis. Am Fam
Physician 67: 2131–2138.
3. Hill DE, Chirukandoth S, Dubey JP (2005) Biology and epidemiology of
Toxoplasma gondii in man and animals. Anim Health Res Rev 6: 41–61.
4. Elmore SA, Jones JL, Conrad PA, Patton S, Lindsay DS, et al. (2010) Toxoplasma
gondii: epidemiology, feline clinical aspects, and prevention. Trends Parasitol 26:
190–196.
5. Hill D, Coss C, Dubey JP, Wroblewski K, Sautter M, et al. (2011) Identification
of a sporozoite-specific antigen from Toxoplasma gondii. J Parasitol 97: 328–337.
6. Munoz-Zanzi CA, Fry P, Lesina B, Hill D (2010) Toxoplasma gondii oocyst-specific
antibodies and source of infection. Emerg Infect Dis 16: 1591–1593.
7. Innes EA (2010) A brief history and overview of Toxoplasma gondii. Zoonoses
Public Health 57: 1–7.
8. Sulzer AJ, Franco EL, Takafuji E, Benenson M, Walls KW, et al. (1986) An
oocyst-transmitted outbreak of toxoplasmosis: patterns of immunoglobulin G
and M over one year. Am J Trop Med Hyg 35: 290–296.
9. Isaac-Renton J, Bowie WR, King A, Irwin GS, Ong CS, et al. (1998) Detection
of Toxoplasma gondii oocysts in drinking water. Appl Environ Microbiol 64:
2278–2280.
10. Aramini JJ, Stephen C, Dubey JP, Engelstoft C, Schwantje H, et al. (1999)
Potential contamination of drinking water with Toxoplasma gondii oocysts.
Epidemiol Infect 122: 305–315.
11. Bahia-Oliveira LM, Jones JL, Azevedo-Silva J, Alves CC, Orefice F, et al. (2003)
Highly endemic, waterborne toxoplasmosis in north Rio de Janeiro state, Brazil.
Emerg Infect Dis 9: 55–62.
12. de Moura L, Bahia-Oliveira LM, Wada MY, Jones JL, Tuboi SH, et al. (2006)
Waterborne toxoplasmosis, Brazil, from field to gene. Emerg Infect Dis 12:
326–329.
13. Dubey JP, Frenkel JK (1972) Cyst-induced toxoplasmosis in cats. J Protozool 19:
155–177.
14. Tenter AM, Heckeroth AR, Weiss LM (2000) Toxoplasma gondii: from animals to
humans. Int J Parasitol 30: 1217–1258.
15. Dabritz HA, Miller MA, Atwill ER, Gardner IA, Leutenegger CM, et al. (2007)
Detection of Toxoplasma gondii-like oocysts in cat feces and estimates of the
environmental oocyst burden. J Am Vet Med Assoc 231: 1676–1684.
16. Dabritz HA, Conrad PA (2010) Cats and Toxoplasma: implications for public
health. Zoonoses Public Health 57: 34–52.
17. Dumetre A, Darde ML (2003) How to detect Toxoplasma gondii oocysts in
environmental samples? FEMS Microbiol Rev 27: 651–661.
18. Lindsay DS, Dubey JP (2009) Long-term survival of Toxoplasma gondii sporulated
oocysts in seawater. J Parasitol 95: 1019–1020.
19. Speer CA, Clark S, Dubey JP (1998) Ultrastructure of the oocysts, sporocysts,
and sporozoites of Toxoplasma gondii. Journal of Parasitology 84: 505–512.
20. Carruthers V, Boothroyd JC (2007) Pulling together: an integrated model of
Toxoplasma cell invasion. Curr Opin Microbiol 10: 83–89.
21. Tilley M, Fichera ME, Jerome ME, Roos DS, White MW (1997) Toxoplasma
gondii sporozoites form a transient parasitophorous vacuole that is impermeable
and contains only a subset of dense-granule proteins. Infect Immun 65:
4598–4605.
22. Boothroyd JC, Dubremetz JF (2008) Kiss and spit: the dual roles of Toxoplasma
rhoptries. Nat Rev Microbiol 6: 79–88.
23. Bahl A, Davis PH, Behnke M, Dzierszinski F, Jagalur M, et al. (2010) A novel
multifunctional oligonucleotide microarray for Toxoplasma gondii. BMC Geno-
mics 11: 603.
24. Cleary MD, Singh U, Blader IJ, Brewer JL, Boothroyd JC (2002) Toxoplasma
gondii asexual development: identification of developmentally regulated genes
and distinct patterns of gene expression. Eukaryot Cell 1: 329–340.
25. Singh U, Brewer JL, Boothroyd JC (2002) Genetic analysis of tachyzoite to
bradyzoite differentiation mutants in Toxoplasma gondii reveals a hierarchy of gene
induction. Mol Microbiol 44: 721–733.
26. Gail M, Gross U, Bohne W (2001) Transcriptional profile of Toxoplasma gondii-
infected human fibroblasts as revealed by gene-array hybridization. Mol Genet
Genomics 265: 905–912.
27. Matrajt M, Donald RG, Singh U, Roos DS (2002) Identification and
characterization of differentiation mutants in the protozoan parasite Toxoplasma
gondii. Mol Microbiol 44: 735–747.
28. Friesen J, Fleige T, Gross U, Bohne W (2008) Identification of novel bradyzoite-
specific Toxoplasma gondii genes with domains for protein-protein interactions by
suppression subtractive hybridization. Mol Biochem Parasitol 157: 228–232.
29. Dzierszinski F, Mortuaire M, Dendouga N, Popescu O, Tomavo S (2001)
Differential expression of two plant-like enolases with distinct enzymatic and
antigenic properties during stage conversion of the protozoan parasite Toxoplasma
gondii. J Mol Biol 309: 1017–1027.
30. Manger ID, Hehl A, Parmley S, Sibley LD, Marra M, et al. (1998) Expressed
sequence tag analysis of the bradyzoite stage of Toxoplasma gondii: identification of
developmentally regulated genes. Infection and Immunity 66: 1632–1637.
31. Radke JR, Behnke MS, Mackey AJ, Radke JB, Roos DS, et al. (2005) The
transcriptome of Toxoplasma gondii. BMC Biol 3: 26.
32. Abrahamsen MS, Clark TG, White MW (1995) An improved method for
isolating RNA from coccidian oocysts. J Parasitol 81: 107–109.
33. Durbin B, Rocke DM (2003) Estimation of transformation parameters for
microarray data. Bioinformatics 19: 1360–1367.
34. Huber W, von Heydebreck A, Sueltmann H, Poustka A, Vingron M (2003)
Parameter estimation for the calibration and variance stabilization of microarray
data. Stat Appl Genet Mol Biol 2: Article3.
35. Kibe MK, Coppin A, Dendouga N, Oria G, Meurice E, et al. (2005)
Transcriptional regulation of two stage-specifically expressed genes in the
protozoan parasite Toxoplasma gondii. Nucleic Acids Res 33: 1722–1736.
36. Buchholz KR, Fritz HM, Chen X, Durbin-Johnson B, Rocke DM, et al. (2011)
Identification of tissue cyst wall components by transcriptome analysis of in vivo
and in vitro Toxoplasma bradyzoites. Eukaryot Cell. DOI:10.1128/EC.05182–11.
37. Kim SK, Karasov A, Boothroyd JC (2007) Bradyzoite-specific surface antigen
SRS9 plays a role in maintaining Toxoplasma gondii persistence in the brain and in
host control of parasite replication in the intestine. Infect Immun 75: 1626–1634.
38. Saeij JP, Arrizabalaga G, Boothroyd JC (2008) A cluster of four surface antigen
genes specifically expressed in bradyzoites, SAG2CDXY, plays an important
role in Toxoplasma gondii persistence. Infect Immun 76: 2402–2410.
39. Bohne W, Gross U, Ferguson DJ, Heesemann J (1995) Cloning and
characterization of a bradyzoite-specifically expressed gene (hsp30/bag1) of
Toxoplasma gondii, related to genes encoding small heat-shock proteins of plants.
Mol Microbiol 16: 1221–1230.
40. Ferguson DJ, Parmley SF, Tomavo S (2002) Evidence for nuclear localisation of
two stage-specific isoenzymes of enolase in Toxoplasma gondii correlates with active
parasite replication. Int J Parasitol 32: 1399–1410.
41. Yang S, Parmley SF (1997) Toxoplasma gondii expresses two distinct lactate
dehydrogenase homologous genes during its life cycle in intermediate hosts.
Gene 184: 1–12.
42. Manger ID, Hehl AB, Boothroyd JC (1998) The surface of Toxoplasma
tachyzoites is dominated by a family of glycosylphosphatidylinositol-anchored
antigens related to SAG1. Infection and Immunity 66: 2237–2244.
43. Jung C, Lee CY, Grigg ME (2004) The SRS superfamily of Toxoplasma surface
proteins. Int J Parasitol 34: 285–296.
44. Kim SK, Boothroyd JC (2005) Stage-specific expression of surface antigens by
Toxoplasma gondii as a mechanism to facilitate parasite persistence. J Immunol
174: 8038–8048.
45. Radke JR, Gubbels MJ, Jerome ME, Radke JB, Striepen B, et al. (2004)
Identification of a sporozoite-specific member of the Toxoplasma SAG
superfamily via genetic complementation. Mol Microbiol 52: 93–105.
46. Possenti A, Cherchi S, Bertuccini L, Pozio E, Dubey JP, et al. (2010) Molecular
characterisation of a novel family of cysteine-rich proteins of Toxoplasma gondii
and ultrastructural evidence of oocyst wall localisation. Int J Parasitol 40:
1639–1649.
47. Fritz HM, Bowyer PW, Bogyo M, Conrad PA, Boothroyd JC (2011) Proteomic
analysis of fractionated Toxoplasma oocysts reveals clues to their environmental
resistance. PLoS One. DOI:10.1371/journal.pone.0029955.
48. Ding M, Kwok LY, Schluter D, Clayton C, Soldati D (2004) The antioxidant
systems in Toxoplasma gondii and the role of cytosolic catalase in defence against
oxidative injury. Mol Microbiol 51: 47–61.
49. Carruthers VG, Sibley LD (1997) Sequential protein secretion from three
distinct organelles of Toxoplasma gondii accompanies invasion of human
fibroblasts. Eur J Cell Biol 73: 114–123.
50. He XL, Grigg ME, Boothroyd JC, Garcia KC (2002) Structure of the
immunodominant surface antigen from the Toxoplasma gondii SRS superfamily.
Nat Struct Biol 9: 606–611.
51. Kasper LH, Khan IA (1993) Role of P30 in host immunity and pathogenesis of
T. gondii infection. Res Immunol 144: 45–48.
52. Tomavo S, Fortier B, Soete M, Ansel C, Camus D, et al. (1991) Characterization
of bradyzoite-specific antigens of Toxoplasma gondii. Infect Immun 59: 3750–3753.
53. Carruthers VB, Tomley FM (2008) Microneme proteins in apicomplexans.
Subcell Biochem 47: 33–45.
54. Lamarque M, Besteiro S, Papoin J, Roques M, Vulliez-Le Normand B, et al.
(2011) The RON2-AMA1 interaction is a critical step in moving junction-
dependent invasion by apicomplexan parasites. PLoS Pathog 7: e1001276.
55. Tyler JS, Boothroyd JC (2011) The C-terminus of Toxoplasma RON2 provides
the crucial link between AMA1 and the host-associated invasion complex. PLoS
Pathog 7: e1001282.
56. Tonkin ML, Roques M, Lamarque MH, Pugniere M, Douguet D, et al. (2011)
Host cell invasion by apicomplexan parasites: insights from the co-structure of
AMA1 with a RON2 peptide. Science 333: 463–467.
57. Alexander DL, Mital J, Ward GE, Bradley P, Boothroyd JC (2005) Identification
of the Moving Junction Complex of Toxoplasma gondii: A Collaboration between
Distinct Secretory Organelles. PLoS Pathog 1: e17.
58. Beckers CJM, Dubremetz JF, Mercereau-Puijalon O, Joiner KA (1994) The
Toxoplasma gondii rhoptry protein ROP2 is inserted into the parasitophorous
vauole membrane, surrounding the intracellular parasite, and is exposed to the
host cell cytoplasm. J Cell Biol 127: 947–961.
59. Saeij JP, Coller S, Boyle JP, Jerome ME, White MW, et al. (2007) Toxoplasma co-
opts host gene expression by injection of a polymorphic kinase homologue.
Nature 445: 324–327.
60. Mercier C, Adjogble KD, Daubener W, Delauw MF (2005) Dense granules: are
they key organelles to help understand the parasitophorous vacuole of all
apicomplexa parasites? Int J Parasitol 35: 829–849.
Toxoplasma gondii Oocyst Transcriptome
PLoS ONE | www.plosone.org 17 February 2012 | Volume 7 | Issue 2 | e29998
61. Kim JY, Ahn HJ, Ryu KJ, Nam HW (2008) Interaction between parasitophor-
ous vacuolar membrane-associated GRA3 and calcium modulating ligand of
host cell endoplasmic reticulum in the parasitism of Toxoplasma gondii.
Korean J Parasitol 46: 209–216.
62. Ahn HJ, Kim S, Kim HE, Nam HW (2006) Interactions between secreted GRA
proteins and host cell proteins across the paratitophorous vacuolar membrane in
the parasitism of Toxoplasma gondii. Korean J Parasitol 44: 303–312.
63. Speer CA, Tilley M, Temple ME, Blixt JA, Dubey JP, et al. (1995) Sporozoites
of Toxoplasma gondii lack dense-granule protein GRA3 and form a unique
parasitophorous vacuole. Mol Biochem Parasitol 75: 75–86.
64. Mai K, Smith NC, Feng ZP, Katrib M, Slapeta J, et al. (2011) Peroxidase
catalysed cross-linking of an intrinsically unstructured protein via dityrosine
bonds in the oocyst wall of the apicomplexan parasite, Eimeria maxima.
Int J Parasitol.
65. Templeton TJ, Lancto CA, Vigdorovich V, Liu C, London NR, et al. (2004)
The Cryptosporidium oocyst wall protein is a member of a multigene family and
has a homolog in Toxoplasma. Infect Immun 72: 980–987.
66. Keeney S, Giroux CN, Kleckner N (1997) Meiosis-specific DNA double-strand
breaks are catalyzed by Spo11, a member of a widely conserved protein family.
Cell 88: 375–384.
67. Trexler M, Banyai L, Patthy L (2000) The LCCL module. Eur J Biochem 267:
5751–5757.
68. Carter V, Shimizu S, Arai M, Dessens JT (2008) PbSR is synthesized in
macrogametocytes and involved in formation of the malaria crystalloids. Mol
Microbiol 68: 1560–1569.
69. Claudianos C, Dessens JT, Trueman HE, Arai M, Mendoza J, et al. (2002) A
malaria scavenger receptor-like protein essential for parasite development. Mol
Microbiol 45: 1473–1484.
70. Saier MH, Jr., Beatty JT, Goffeau A, Harley KT, Heijne WH, et al. (1999) The
major facilitator superfamily. J Mol Microbiol Biotechnol 1: 257–279.
71. Seol W, Shatkin AJ (1992) Site-directed mutants of Escherichia coli alpha-
ketoglutarate permease (KgtP). Biochemistry 31: 3550–3554.
72. Marger MD, Saier MH, Jr. (1993) A major superfamily of transmembrane
facilitators that catalyse uniport, symport and antiport. Trends Biochem Sci 18:
13–20.
73. Woof JM (2002) The human IgA-Fc alpha receptor interaction and its blockade
by streptococcal IgA-binding proteins. Biochem Soc Trans 30: 491–494.
74. Pleass RJ, Areschoug T, Lindahl G, Woof JM (2001) Streptococcal IgA-binding
proteins bind in the Calpha 2-Calpha 3 interdomain region and inhibit binding
of IgA to human CD89. J Biol Chem 276: 8197–8204.
75. Cerutti A, Chen K, Chorny A (2011) Immunoglobulin responses at the mucosal
interface. Annu Rev Immunol 29: 273–293.
76. Saeij JP, Boyle JP, Coller S, Taylor S, Sibley LD, et al. (2006) Polymorphic
secreted kinases are key virulence factors in toxoplasmosis. Science 314:
1780–1783.
77. Reese ML, Zeiner GM, Saeij JP, Boothroyd JC, Boyle JP (2011) Polymorphic
family of injected pseudokinases is paramount in Toxoplasma virulence. Proc Natl
Acad Sci U S A 108: 9625–9630.
78. Mineo JR, Kasper LH (1994) Attachment of Toxoplasma gondii to host cells
involves major surface protein, SAG-1 (P30). Exp Parasitol 79: 11–20.
79. Rachinel N, Buzoni-Gatel D, Dutta C, Mennechet FJ, Luangsay S, et al. (2004)
The induction of acute ileitis by a single microbial antigen of Toxoplasma gondii.
J Immunol 173: 2725–2735.
80. Dzierszinski F, Mortuaire M, Cesbron-Delauw MF, Tomavo S (2000) Targeted
disruption of the glycosylphosphatidylinositol-anchored surface antigen SAG3
gene in Toxoplasma gondii decreases host cell adhesion and drastically reduces
virulence in mice. Mol Microbiol 37: 574–582.
81. Lekutis C, Ferguson DJ, Grigg ME, Camps M, Boothroyd JC (2001) Surface
antigens of Toxoplasma gondii: variations on a theme. Int J Parasitol 31:
1285–1292.
82. Guerardel Y, Leleu D, Coppin A, Lienard L, Slomianny C, et al. (2005)
Amylopectin biogenesis and characterization in the protozoan parasite
Toxoplasma gondii, the intracellular development of which is restricted in the
HepG2 cell line. Microbes Infect 7: 41–48.
83. Fritz H, Barr B, Packham A, Melli A, Conrad PA (2011) Methods to produce
and safely work with large numbers of Toxoplasma gondii oocysts and bradyzoite
cysts. J Microbiol Methods. DOI:10.1016/j.mimet.2011.10.010.
84. Dumetre A, Darde ML (2004) Purification of Toxoplasma gondii oocysts by cesium
chloride gradient. J Microbiol Methods 56: 427–430.
85. Huskinson-Mark J, Araujo FG, Remington JS (1991) Evaluation of the effect of
drugs on the cyst form of Toxoplasma gondii. J Infect Dis 164: 170–171.
86. Gautier L, Cope L, Bolstad BM, Irizarry RA (2004) affy–analysis of Affymetrix
GeneChip data at the probe level. Bioinformatics 20: 307–315.
87. R Development Core Team (2009) R: A language and environment for
statistical computing. R Foundation for Statistical Computing V, Austria. ISBN
3-900051-07-0, URL http://www.R-project.org/.
88. Durbin BP, Hardin JS, Hawkins DM, Rocke DM (2002) A variance-stabilizing
transformation for gene-expression microarray data. Bioinformatics 18 Suppl 1:
S105–110.
89. Rocke DLG, Tillinghast J, Durbin-Johnson B, Wu S LMGene: LMGene
Software for Data Transformation and Identification of Differentially Expressed
Genes in Gene Expression Arrays. R package version 2.4.0. http://CRAN.R-
project.org/package =LMGene.
Toxoplasma gondii Oocyst Transcriptome
PLoS ONE | www.plosone.org 18 February 2012 | Volume 7 | Issue 2 | e29998
